CAS_NUMBER	ID	COMPOUND_CODE	COMPOUND_NAME	FMLA	MOLECULAR_WEIGHT	KOWLOGP	STRUCTURECATEGORY	SMILES	AUTHORS	JOURNAL	PUBLICATION_DATE	VOLUME_NUMBER	START_PAGE	SOURCE_URL	ASSAY_CLASS_NAME	ASSAY_NAME	SPECIES_STRAIN	ENDPOINT_NAME	ENDPOINT_VALUE	ENDPOINT_UNIT	PROTEIN_SUBTYPE	PROTEIN_DOMAIN	ROUTE_OF_COMPOUND
50-28-2	1	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using MCF-7 Cells	Human	logRBA	2				
50-28-2	2	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	2				
50-28-2	3	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO.	Environ. Health Perspect. 	1995	103	113		Binding	Relative binding affinity (RBA) for estrogen receptor compared to E2	Human	logRBA	2				
50-28-2	4	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Arrendale RF, Schmidt WF, Thompson CB, Nanavati NT.	J. Med. Chem.	1989	32	192		Binding	Relative binding affinity for estrogen receptor compared to estradiol	Human	logRBA	2				
50-28-2	5	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	2				
50-28-2	6	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Salman M, Ray S, Anand N, Agarwal AK, Singh MM, Setty BS, Kamboj VP.	J. Med. Chem.	1986	29	1801		Binding	Relative binding affinity for uterine cytosolic estrogen receptors of immature rats	Rat	logRBA	2				
50-28-2	7	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM.	Toxicol. Sci. 	2000	54	138		Binding	relative binding affinity (RBA) for ER competitive-binding assays	Rat	logRBA	2				
50-28-2	8	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		Bioorg. Med. Chem. Lett.	1996	6	2537		Binding	Relative binding affinity for rat uterine estrogen receptor	Rat	logRBA	2				
50-28-2	9	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Laws SC, Yavanhxay S, Cooper RL, Eldridge JC.	Toxicol. Sci. 	2006	94	46		Binding	rat uterine cytosolic (RUC) ER-competitive binding assay	Rat	logRBA	2				
50-28-2	10	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Mouse uterine cytosol	Mouse	logRBA	2				
50-28-2	11	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Waller CL, Minor DL, McKinney JD.	Environ. Health Perspect. 	1995	103	702		Binding	Competitive binding concentration of unlabeled inhibitor yielding half-maximal specific binding relative to estradiol	Mouse	logRBA	2				
50-28-2	12	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr.	Chem. Res. Toxicol. 	1996	9	1240		Binding	Competitive estrogen receptor binding assays using mouse uterine cytosol	Mouse	logRBA	2				
50-28-2	13	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Walter G, Liebl R, von Angerer E.	Bioorg. Med. Chem. Lett.	2004	14	4659		Binding	Relative binding affinity for Estrogen receptor of Calf uterine cytosol	Cattle	logRBA	2				
50-28-2	14	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Delbarre A, Oberlin R, Roques BP, Borgna JL, Rochefort H, Le Pecq JB, Jacquemin-Sablon A.	J. Med. Chem.	1985	28	752		Binding	The compound was tested for relative binding affinity against calf uterine receptor using [3H]estradiol as radioligand	Cattle	logRBA	2				
50-28-2	15	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	2			LBD	
50-28-2	16	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	2			LBD	
50-28-2	17	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	2			LBD	
50-28-2	18	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Jurgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Naerum L, Wassermann K.	Bioorg. Med. Chem. Lett.	2000	10	2383		Binding	Estrogen receptor binding affinity by displacement of [3H]17-beta-estradiol in ER-rich cytosol from rabbit uterine tissue	Rabbit	logRBA	2		alpha		
50-28-2	19	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Jurgensen AS, Jacobsen P, Christiansen LB, Bury PS, Kanstrup A, Thorpe SM, Bain S, Naerum L, Wassermann K.	Bioorg. Med. Chem. Lett.	2000	10	399		Binding	Binding affinity for estrogen receptor of rabbit uterine skeletal muscle tissue	Rabbit	logRBA	2		alpha		
50-28-2	20	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Henke BR, Drewry DH, Jones SA, Stewart EL, Weaver SL, Wiethe RW.	Bioorg. Med. Chem. Lett.	2001	11	1939		Binding	Ability to displace [3H]17-beta-estradiol from Estrogen receptor alpha by scintillation proximity assay.		logRBA	2		alpha		
50-28-2	21	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Adamczyk M, Reddy RE, Yu Z.	Bioorg. Med. Chem. Lett.	2002	12	1283		Binding	Displacement of radioligand from Estrogen receptor alpha		logRBA	2		alpha		
50-28-2	22	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Smith RA, Chen J, Mader MM, Muegge I, Moehler U, Katti S, Marrero D, Stirtan WG, Weaver DR, Xiao H, Carley W.	Bioorg. Med. Chem. Lett.	2002	12	2875		Binding	Binding affinity for Estrogen receptor alpha (ER alpha) receptor		logRBA	2		alpha		
50-28-2	23	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Christiansen LB, Wenckens M, Bury PS, Gissel B, Hansen BS, Thorpe SM, Jacobsen P, Kanstrup A, Jurgensen AS, Naerum L, Wassermann K.	Bioorg. Med. Chem. Lett.	2002	12	17		Binding	Displacement of [3H]17-beta-estradiol from Estrogen receptor of rabbit uterine tissue	Rabbit	logRBA	2		alpha		
50-28-2	24	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	McKie JA, Bhagwat SS, Brady H, Doubleday M, Gayo L, Hickman M, Jalluri RK, Khammungkhune S, Kois A, Mortensen D, Richard N, Sapienza J, Shevlin G, Stein B, Sutherland M.	Bioorg. Med. Chem. Lett.	2004	14	3407		Binding	Binding affinity against estrogen receptor alpha relative to E2		logRBA	2		alpha		
50-28-2	25	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Binding	Binding affinity towards estrogen receptor alpha by [3H]17-beta-estradiol displacement.		logRBA	2		alpha		
50-28-2	26	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sharma U, Marquis JC, Nicole Dinaut A, Hillier SM, Fedeles B, Rye PT, Essigmann JM, Croy RG.	Bioorg. Med. Chem. Lett.	2004	14	3829		Binding	Relative binding affinity for rabbit uterine estrogen receptor compared to estradiol	Rabbit	logRBA	2		alpha		
50-28-2	27	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Compton DR, Carlson KE, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	2004	14	5681		Binding	Binding affinity for Estrogen receptor alpha compared to estradiol (100%)		logRBA	2		alpha		
50-28-2	28	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ahmed N, Dubuc C, Rousseau J, BÃ©nard F, van Lier JE.	Bioorg. Med. Chem. Lett.	2007	17	3212		Binding	Relative binding affinity for ERalpha by competitive [3H]estradiol binding assay relative to estradiol		logRBA	2		alpha		
50-28-2	29	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kishton RJ, Miller SE, Perry H, Lynch T, Patel M, Gore VK, Akkaraju GR, Varadarajan S.	Bioorg. Med. Chem.	2011	19	5093		Binding	Binding affinity to estrogen receptor-alpha after 2 hrs by TR-FRET assay		logRBA	2		alpha		
50-28-2	30	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]estradiol from estrogen receptor in squirrel monkey	Monkey	logRBA	2		alpha		
50-28-2	31	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]estradiol from estrogen receptor in immature rabbit	Rabbit	logRBA	2		alpha		
50-28-2	32	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Binding	Binding affinity for estrogen receptor, by competition with [3H]estradiol		logRBA	2		alpha		
50-28-2	33	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Wiese TE, Polin LA, Palomino E, Brooks SC.	J. Med. Chem.	1997	40	3659		Binding	Estrogen receptor (ER) binding affinity		logRBA	2		alpha		
50-28-2	34	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Grese TA, Cho S, Finley DR, Godfrey AG, Jones CD, Lugar CW 3rd, Martin MJ, Matsumoto K, Pennington LD, Winter MA, Adrian MD, Cole HW, Magee DE, Phillips DL, Rowley ER, Short LL, Glasebrook AL, Bryant HU.	J. Med. Chem.	1997	40	146		Binding	In vitro relative binding affinity by competition with [3H]17-beta-estradiol for estrogen receptor in MCF-7 cell lysate		logRBA	2		alpha		
50-28-2	35	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Binding	Inhibitory concentration against estrogen receptor alpha using radioligand binding assay.		logRBA	2		alpha		
50-28-2	36	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Pigeon P, Top S, VessiÃ¨res A, HuchÃ© M, Hillard EA, Salomon E, Jaouen G.	J. Med. Chem.	2005	48	2814		Binding	Relative binding affinity for Estrogen receptor alpha		logRBA	2		alpha		
50-28-2	37	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SedlÃ¡k D, NovÃ¡k P, Kotora M, BartÅ¯nek P.	J. Med. Chem.	2010	53	4290		Binding	Ratio of 17-beta-estradiol IC50 to compound IC50 for ERalpha		logRBA	2		alpha		
50-28-2	38	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		Bioorg. Med. Chem. Lett.	1996	6	201		Binding	Binding affinity against estrogen receptor relative to [3H]estradiol		logRBA	2		alpha		
50-28-2	39	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		Bioorg. Med. Chem. Lett.	1997	7	887		Binding	Affinity against estrogen receptor in MCF-7 cell lysate by competitive displacement of [3H]estradiol		logRBA	2		alpha		
50-28-2	40	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hegazy ME, El-Hamd H Mohamed A, El-Halawany AM, Djemgou PC, Shahat AA, ParÃ© PW.	J. Nat. Prod.	2011	74	937		Binding	Inhibition of fluorescence-labeled 17beta-estradiol binding to ERalpha receptor at 0.1 microM after 2 hrs by fluorometric analysis		logRBA	2		alpha		
50-28-2	41	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hegazy ME, El-Hamd H Mohamed A, El-Halawany AM, Djemgou PC, Shahat AA, ParÃ© PW.	J. Nat. Prod.	2011	74	937		Binding	Inhibition of fluorescence-labeled 17beta-estradiol binding to ERalpha receptor after 2 hrs by fluorometric analysis		logRBA	2		alpha		
50-28-2	42	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Pinney KG, Bounds AD, Dingeman KM, Mocharla VP, Pettit GR, Bai R, Hamel E.	Bioorg. Med. Chem. Lett.	1999	9	1081		Binding	Relative binding affinity for estrogen receptor compared to estradiol		logRBA	2		alpha		
50-28-2	43	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Miller CP, Jirkovsky I, Tran BD, Harris HA, Moran RA, Komm BS.	Bioorg. Med. Chem. Lett.	2000	10	147		Binding	Displacement of [3H]17-beta-estradiol from human Estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	44	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tedesco R, Youngman MK, Wilson SR, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	2001	11	1281		Binding	Relative binding affinity for human Estrogen receptor alpha compared to estradiol (E2)	Human	logRBA	2		alpha		
50-28-2	45	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yang C, Edsall R Jr, Harris HA, Zhang X, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2004	12	2553		Binding	solid phase radioligand binding assay of ERa	Human	logRBA	2		alpha		
50-28-2	46	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Miller CP, Collini MD, Harris HA.	Bioorg. Med. Chem. Lett.	2003	13	2399		Binding	Binding affinity towards human estrogen receptor alpha(ERalpha)	Human	logRBA	2		alpha		
50-28-2	47	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sibley R, Hatoum-Mokdad H, Schoenleber R, Musza L, Stirtan W, Marrero D, Carley W, Xiao H, Dumas J.	Bioorg. Med. Chem. Lett.	2003	13	1919		Binding	In vitro binding affinity for estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	48	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tan Q, Birzin ET, Chan W, Tien Yang Y, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3747		Binding	Binding affinity for human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	49	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tan Q, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3753		Binding	Binding affinity for human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	50	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor alpha in competitive binding assay	Human	logRBA	2		alpha		
50-28-2	51	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, DiNinno F, Morgan JD 2nd, Chen HY, Wu JY, Gude C, Kim S, Chan W, Birzin ET, Tien Yang Y, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3861		Binding	Binding potency for human ER alpha	Human	logRBA	2		alpha		
50-28-2	52	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, DiNinno F, Morgan JD 2nd, Wu JY, Chen HY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3865		Binding	Binding potency for human ER alpha	Human	logRBA	2		alpha		
50-28-2	53	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Collini MD, Kaufman DH, Manas ES, Harris HA, Henderson RA, Xu ZB, Unwalla RJ, Miller CP.	Bioorg. Med. Chem. Lett.	2004	14	4925		Binding	Binding affinity for human Estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	54	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tan Q, Blizzard TA, Morgan JD 2nd, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, Warrier S, Yudkovitz J, Wilkinson HA, Sharma N, Fitzgerald PM, Li S, Colwell L, Fisher JE, Adamski S, Reszka AA, Kimmel D, DiNinno F, Rohrer SP, Freedman LP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	1675		Binding	Inhibition of estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	55	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Liu J, Birzin ET, Chan W, Yang YT, Pai LY, Dasilva C, Hayes EC, Mosley RT, Dininno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	715		Binding	Binding affinity for human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	56	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Dininno F, Morgan JD 2nd, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PM, Sharma N, Li Y, Zhang Z, Hayes EC, Dasilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	107		Binding	Inhibition of bindign to recombinant human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	57	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA.	Bioorg. Med. Chem. Lett.	2005	15	3137		Binding	Inhibition of human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	58	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2005	15	4520		Binding	Binding affinity for human Estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	59	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Chesworth R, Wessel MD, Heyden L, Mangano FM, Zawistoski M, Gegnas L, Galluzzo D, Lefker B, Cameron KO, Tickner J, Lu B, Castleberry TA, Petersen DN, Brault A, Perry P, Ng O, Owen TA, Pan L, Ke HZ, Brown TA, Thompson DD, DaSilva-Jardine P.	Bioorg. Med. Chem. Lett.	2005	15	5562		Binding	Displacement of [3H]17beta-estradiol from recombinant human ERalpha expressed in 293T cells	Human	logRBA	2		alpha		
50-28-2	60	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Gude C, Morgan JD 2nd, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Sharma N, Fitzgerald PM, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2006	16	834		Binding	Binding affinity to human ERalpha	Human	logRBA	2		alpha		
50-28-2	61	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sun W, Cama LD, Birzin ET, Warrier S, Locco L, Mosley R, Hammond ML, Rohrer SP.	Bioorg. Med. Chem. Lett.	2006	16	1468		Binding	Binding affinity to ERalpha	Human	logRBA	2		alpha		
50-28-2	62	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML, Mosley RT, Fitzgerald PM, Sharma N, McKeever BM, Nilsson S, Carlquist M, Thorsell A, Locco L, Katz R, Frisch K, Birzin ET, Wilkinson HA, Mitra S, Cai S, Hayes EC, Schaeffer JM, Rohrer SP.	Bioorg. Med. Chem. Lett.	2006	16	3489		Binding	Binding affinity to ERalpha by scintillation proximity assay	Human	logRBA	2		alpha		
50-28-2	63	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Wilkening RR, Ratcliffe RW, Fried AK, Meng D, Sun W, Colwell L, Lambert S, Greenlee M, Nilsson S, Thorsell A, Mojena M, Tudela C, Frisch K, Chan W, Birzin ET, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2006	16	3896		Binding	Binding affinity to human ERalpha	Human	logRBA	2		alpha		
50-28-2	64	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Parker DL Jr, Meng D, Ratcliffe RW, Wilkening RR, Sperbeck DM, Greenlee ML, Colwell LF, Lambert S, Birzin ET, Frisch K, Rohrer SP, Nilsson S, Thorsell AG, Hammond ML.	Bioorg. Med. Chem. Lett.	2006	16	4652		Binding	Binding affinity to human recombinant ERalpha by scintillation proximity assay	Human	logRBA	2		alpha		
50-28-2	65	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST.	Bioorg. Med. Chem. Lett.	2007	17	902		Binding	Inhibition of human ERalpha by radioligand binding assay	Human	logRBA	2		alpha		
50-28-2	66	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Gude C, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Holmes MA, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2007	17	2944		Binding	Binding affinity to human recombinant ERalpha by scintillation proximity assay	Human	logRBA	2		alpha		
50-28-2	67	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Vu AT, Campbell AN, Harris HA, Unwalla RJ, Manas ES, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	4053		Binding	Inhibition of human ERalpha	Human	logRBA	2		alpha		
50-28-2	68	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Gude C, Morgan JD 2nd, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2007	17	6295		Binding	Binding affinity at human recombinant ERalpha	Human	logRBA	2		alpha		
50-28-2	69	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ohta K, Chiba Y, Ogawa T, Endo Y.	Bioorg. Med. Chem. Lett.	2008	18	5050		Binding	Binding affinity to human recombinant ERalpha receptor by liquid scintillation counter	Human	logRBA	2		alpha		
50-28-2	70	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Rivera-Guevara C, PÃ©rez-Alvarez V, GarcÃ­a-Becerra R, Ordaz-Rosado D, Morales-RÃ­os MS, HernÃ¡ndez-Gallegos E, Cooney AJ, Bravo-GÃ³mez ME, Larrea F, Camacho J.	Bioorg. Med. Chem.	2010	18	5593		Binding	Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells after 18 hrs by liquid scintillation counting	Human	logRBA	2		alpha		
50-28-2	71	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mller G, Deluca D, Gege C, Rosinus A, Kowalik D, Peters O, Droescher P, Elger W, Adamski J, Hillisch A.	Bioorg. Med. Chem. Lett.	2009	19	6740		Binding	Displacement of [3H]17beta-estradiol from human ERalpha expressed in SF9 cells	Human	logRBA	2		alpha		
50-28-2	72	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Arrendale RF, Schmidt WF, Thompson CB, Nanavati NT.	J. Med. Chem.	1989	32	192		Binding	Displacement of [3H]-estradiol from estrogen receptor (ER)	Human	logRBA	2		alpha		
50-28-2	73	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Jones CD, Blaszczak LC, Goettel ME, Suarez T, Crowell TA, Mabry TE, Ruenitz PC, Srivatsan V.	J. Med. Chem.	1992	35	931		Binding	Displacement of [3H]estradiol from Estrogen receptor in MCF-7 cells	Human	logRBA	2		alpha		
50-28-2	74	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Jones CD, Blaszczak LC, Goettel ME, Suarez T, Crowell TA, Mabry TE, Ruenitz PC, Srivatsan V.	J. Med. Chem.	1992	35	931		Binding	Binding affinity for Estrogen receptor in MCF-Cells relative to estradiol	Human	logRBA	2		alpha		
50-28-2	75	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hoyte RM, Borderon K, Bryson K, Allen R, Hochberg RB, Brown TJ.	J. Med. Chem.	1994	37	1224		Binding	Relative binding affinity for estrogen receptor in MCF-7 cell cystosol extract	Human	logRBA	2		alpha		
50-28-2	76	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hossain MB, van der Helm D, Schmitz FJ, Pordesimo EO, Magarian RA, Meyer KL, Overacre LB, Day BW.	J. Med. Chem.	1994	37	1670		Binding	Percent relative binding affinity (RBA) for estrogen receptor compared to estradiol	Human	logRBA	2		alpha		
50-28-2	77	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Gilbert NE, Liberto MM, Sharp DW, Lin YC, Brueggemeier RW.	J. Med. Chem.	1996	39	1917		Binding	Relative binding affinity for estrogen receptor compared to estradiol	Human	logRBA	2		alpha		
50-28-2	78	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Gilbert NE, Liberto MM, Sharp DW, Lin YC, Brueggemeier RW.	J. Med. Chem.	1996	39	1917		Binding	Relative binding affinity(RBA) of estradiol with respect to compound (using estrogen receptor preparations)	Human	logRBA	2		alpha		
50-28-2	79	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hamann LG, Farmer LJ, Johnson MG, Bender SL, Mais DE, Wang MW, Crombie D, Goldman ME, Jones TK.	J. Med. Chem.	1996	39	1778		Binding	Binding affinity for human estrogen receptor	Human	logRBA	2		alpha		
50-28-2	80	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lobaccaro C, Pons JF, Duchesne MJ, Auzou G, Pons M, Nique F, Teutsch G, Borgna JL.	J. Med. Chem.	1997	40	2217		Binding	Relative affinity constant for cytosolic estrogen receptor	Human	logRBA	2		alpha		
50-28-2	81	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Bhat AS, Coughenour HD, Gilbert NE, Brueggemeier RW.	J. Med. Chem.	1997	40	3756		Binding	Relative binding affinity (RBA) for the estrogen receptor	Human	logRBA	2		alpha		
50-28-2	82	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative affinity for estrogen receptor of Human Breast cancer or normal uterine cytosol (3.3%ethanol) compared to estradiol	Human	logRBA	2		alpha		
50-28-2	83	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative Binding Affinity for estrogen receptor in Human Breast cancer or normal uterine cytosol in 2.5%DMF compared to estradiol	Human	logRBA	2		alpha		
50-28-2	84	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative Binding Affinity for estrogen receptor in Human Breast cancer or normal uterine cytosol in 3.3%ethanol compared to estradiol	Human	logRBA	2		alpha		
50-28-2	85	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative Binding Affinity for estrogen receptor in Human Breast cancer or normal uterine cytosol in 2.5%DMF  compared to estradiol	Human	logRBA	2		alpha		
50-28-2	86	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	1999	42	2456		Binding	Binding affinity for human Estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	87	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kraft KS, Ruenitz PC, Bartlett MG.	J. Med. Chem.	1999	42	3126		Binding	Displacement of [3H]17-beta-estradiol from human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	88	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Bertini S, Papi C, Carlson KE, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2001	44	4288		Binding	Relative binding affinity for human estrogen receptor alpha by displacement of [3H]-estradiol	Human	logRBA	2		alpha		
50-28-2	89	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha.	Human	logRBA	2		alpha		
50-28-2	90	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Antonello M, Bertini S, Ortore G, Placanica G, Rapposelli S, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2003	46	4032		Binding	Relative binding affinity  for human estrogen receptor alpha compared to [3H]estradiol	Human	logRBA	2		alpha		
50-28-2	91	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Nussbaumer P, Winiski AP, Billich A.	J. Med. Chem.	2003	46	5091		Binding	Affinity of compound towards human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	92	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Burke PJ, Koch TH.	J. Med. Chem.	2004	47	1193		Binding	Inhibition of [3H]E2 binding to estrogen receptor alpha in MCF-7 cell lysate	Human	logRBA	2		alpha		
50-28-2	93	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY, Yang YT, Mosley RT, Fitzgerald PM, Sharma N, Dahllund J, Thorsell AG, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	J. Med. Chem.	2004	47	2171		Binding	Binding affinity towards human recombinant Estrogen receptor alpha was determined	Human	logRBA	2		alpha		
50-28-2	94	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mewshaw RE, Edsall RJ Jr, Yang C, Manas ES, Xu ZB, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2005	48	3953		Binding	Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha expressed in Escherichia coli	Human	logRBA	2		alpha		
50-28-2	95	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Binding	Inhibition of [3H]estradiol binding to human estrogen receptor alpha expressed in HeLa cells	Human	logRBA	2		alpha		
50-28-2	96	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hoekstra WJ, Patel HS, Liang X, Blanc JB, Heyer DO, Willson TM, Iannone MA, Kadwell SH, Miller LA, Pearce KH, Simmons CA, Shearin J.	J. Med. Chem.	2005	48	2243		Binding	Binding affinity for human estrogen receptor alpha	Human	logRBA	2		alpha		
50-28-2	97	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yoo J, Dence CS, Sharp TL, Katzenellenbogen JA, Welch MJ.	J. Med. Chem.	2005	48	6366		Binding	Relative binding affinity towards human estrogen receptor alpha using [3H]estradiol upon incubation at 0 degree C for 18-24 h	Human	logRBA	2		alpha		
50-28-2	98	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	GÃ¼ngr T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.	J. Med. Chem.	2006	49	2440		Binding	Displacement of [3H]estrone from ER alpha	Human	logRBA	2		alpha		
50-28-2	99	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kinzel O, Fattori D, Muraglia E, Gallinari P, Nardi MC, Paolini C, Roscilli G, Toniatti C, Gonzalez Paz O, Laufer R, Lahm A, Tramontano A, Cortese R, De Francesco R, Ciliberto G, Koch U.	J. Med. Chem.	2006	49	5404		Binding	Binding affinity to human ER alpha	Human	logRBA	2		alpha		
50-28-2	100	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Zhao L, Jin C, Mao Z, Gopinathan MB, Rehder K, Brinton RD.	J. Med. Chem.	2007	50	4471		Binding	Binding affinity to human ERalpha	Human	logRBA	2		alpha		
50-28-2	101	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Djiogue S, Halabalaki M, Alexi X, Njamen D, Fomum ZT, Alexis MN, Skaltsounis AL.	J. Nat. Prod.	2009	72	1603		Binding	Displacement of fluorescent estrogen ES2 from human recombinant ERalpha by fluorescence polarization assay relative to 17-beta-estradiol	Human	logRBA	2		alpha		
50-28-2	102	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Schmid CR, Sluka JP, Duke KM, Glasebrook AW.	Bioorg. Med. Chem. Lett.	1999	9	523		Binding	Displacement of [3H]17-beta-estradiol from estrogen receptor of MCF-7 cell lysates relative to 17-beta-estradiol	Human	logRBA	2		alpha		
50-28-2	103	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	2		alpha		
50-28-2	104	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Goswami R, Harsy SG, Heiman DF, Katzenellenbogen JA.	J. Med. Chem.	1980	23	1002		Binding	Relative binding affinity for sheep uterine estrogen receptor relative to estradiol as Ka(compound)/Ka(estradiol) x 100	Sheep	logRBA	2		alpha		
50-28-2	105	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Heiman DF, Senderoff SG, Katzenellenbogen JA, Neeley RJ.	J. Med. Chem.	1980	23	994		Binding	Binding affinity towards uterine estrogen receptor relative to that of estradiol expressed by RAC x 100, which is the ratio of association constants (Ka cornpound/Ka estradiol) x 100.	Sheep	logRBA	2		alpha		
50-28-2	106	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hanson RN, Napolitano E, Fiaschi R.	J. Med. Chem.	1990	33	3155		Binding	Relative binding affinity for estrogen receptor of lamb uterus at 0C	Sheep	logRBA	2		alpha		
50-28-2	107	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kym PR, Anstead GM, Pinney KG, Wilson SR, Katzenellenbogen JA.	J. Med. Chem.	1993	36	3910		Binding	Relative binding affinity for lamb uterine estrogen receptor by displacement of [3H]estradiol	Sheep	logRBA	2		alpha		
50-28-2	108	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	el Garrouj D, Aliau S, Aumelas A, Borgna JL.	J. Med. Chem.	1995	38	2339		Binding	Relative affinity constant for lamb cytosolic estrogen receptor binding compared to [3H]estradiol	Sheep	logRBA	2		alpha		
50-28-2	109	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	1995	38	429		Binding	Relative binding affinity was measured on estrogen receptor of lamb uterine cytosol.	Sheep	logRBA	2		alpha		
50-28-2	110	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	1995	38	429		Binding	Relative binding affinity was measured on estrogen receptor of lamb uterine cytosol.	Sheep	logRBA	2		alpha		
50-28-2	111	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	1995	38	2774		Binding	Relative Binding affinity was determined against estrogen receptor of lamb uterine cytosol at 0 degree Celsius relative to estradiol	Sheep	logRBA	2		alpha		
50-28-2	112	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	1995	38	2774		Binding	Relative Binding affinity was determined against estrogen receptor of lamb uterine cytosol at 25 degree Celsius relative to estradiol	Sheep	logRBA	2		alpha		
50-28-2	113	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	1999	42	2456		Binding	Binding affinity for lamb uterine estrogen receptor	Sheep	logRBA	2		alpha		
50-28-2	114	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Aliau S, Delettre G, Mattras H, El Garrouj D, Nique F, Teutsch G, Borgna JL.	J. Med. Chem.	2000	43	613		Binding	Relative affinity constant (RAC) for lamb uterine estrogen receptor alpha by displacement of [3H]estradiol	Sheep	logRBA	2		alpha		
50-28-2	115	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Bertini S, Papi C, Carlson KE, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2001	44	4288		Binding	Relative binding affinity for sheep uterine estrogen receptor by displacement of [3H]estradiol	Sheep	logRBA	2		alpha		
50-28-2	116	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Carlson KE, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	1998	8	3589		Binding	Relative binding affinity for lamb uterine estrogen receptor relative to 17-beta-estradiol	Sheep	logRBA	2		alpha		
50-28-2	117	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	2		alpha	Full-length	
50-28-2	118	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	2		alpha	Full-length	
50-28-2	119	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	2		alpha	Full-length	
50-28-2	120	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	2		alpha	Full-length	
50-28-2	121	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	2		alpha	Full-length	
50-28-2	122	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, DiNinno F, Chen HY, Kim S, Wu JY, Chan W, Birzin ET, Yang YT, Pai LY, Hayes EC, DaSilva CA, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	3912		Binding	human estrogen receptor alpha binding using scintillation proximity assay	Human	logRBA	2		alpha	Full-length	
50-28-2	123	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Dykstra KD, Guo L, Birzin ET, Chan W, Yang YT, Hayes EC, DaSilva CA, Pai LY, Mosley RT, Kraker B, Fitzgerald PM, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2007	17	2322		Binding	Displacement of [3H]estradiol from full length human recombinant ERalpha after 3 hrs by scintillation proximity assay	Human	logRBA	2		alpha	Full-length	
50-28-2	124	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Fang J, Akwabi-Ameyaw A, Britton JE, Katamreddy SR, Navas F 3rd, Miller AB, Williams SP, Gray DW, Orband-Miller LA, Shearin J, Heyer D.	Bioorg. Med. Chem. Lett.	2008	18	5075		Binding	Displacement of [3H]estradiol from full length biotinylated human ERalpha by scintillation proximity assay	Human	logRBA	2		alpha	Full-length	
50-28-2	125	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hu JY, Aizawa T.	Water Res.	2003	37	1213		Binding	human receptor binding competition assay of ER	Human	logRBA	2		alpha	Full-length	
50-28-2	126	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Binding	Relative binding affinity (RBA) at Human estrogen receptor alpha (radiometric binding assay with [3H]estradiol using full-length human ER alpha)	Human	logRBA	2		alpha	Full-length	
50-28-2	127	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	2012	55	528		Binding	Relative Ligand Binding Affinities for ERa	Human	logRBA	2		alpha	Full-length	
50-28-2	128	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	2		alpha	Full-length	
50-28-2	129	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	2		alpha	Full-length	
50-28-2	130	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	2		alpha	Full-length	
50-28-2	131	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	2		alpha	Full-length	
50-28-2	132	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hanson RN, Lee CY, Friel CJ, Dilis R, Hughes A, DeSombre ER.	J. Med. Chem.	2003	46	2865		Binding	Percent relative binding affinity for estrogen receptor ligand binding domain expressed in BL21 cells at 2C	Escherichia coli	logRBA	2		alpha	LBD	
50-28-2	133	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hanson RN, Lee CY, Friel CJ, Dilis R, Hughes A, DeSombre ER.	J. Med. Chem.	2003	46	2865		Binding	Percent relative binding affinity for estrogen receptor ligand binding domain expressed in BL21 cells at 25 degree C	Escherichia coli	logRBA	2		alpha	LBD	
50-28-2	134	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	James DA, Swamy N, Paz N, Hanson RN, Ray R.	Bioorg. Med. Chem. Lett.	1999	9	2379		Binding	Displacement of [3H]estradiol from estrogen receptor-ligand binding domain		logRBA	2		alpha	LBD	
50-28-2	135	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2003	11	3457		Binding	solid phase radioligand binding assay of ERa	Human	logRBA	2		alpha	LBD	
50-28-2	136	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ullrich JW, Unwalla RJ, Singhaus RR Jr, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	118		Binding	Inhibition of human LBD of of ERalpha	Human	logRBA	2		alpha	LBD	
50-28-2	137	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Labaree DC, Zhang JX, Harris HA, OConnor C, Reynolds TY, Hochberg RB.	J. Med. Chem.	2003	46	1886		Binding	Binding of [3H]E2 alkyl ester to human estrogen receptor alpha ligand binding domain expressed in Escherichia coli	Human	logRBA	2		alpha	LBD	
50-28-2	138	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay against human ER alpha expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand	Human	logRBA	2		alpha	LBD	
50-28-2	139	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Roelens F, Heldring N, Dhooge W, Bengtsson M, Comhaire F, Gustafsson JA, Treuter E, De Keukeleire D.	J. Med. Chem.	2006	49	7357		Binding	Displacement of [3H]E2 from human recombinant ERalpha LBD by SPA	Human	logRBA	2		alpha	LBD	
50-28-2	140	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SchÃ¤fer A, Wellner A, Gust R.	CHEMMEDCHEM	2011	6	794		Binding	Relative binding affinities (RBA) at hERa as determined by HAP assay	Human	logRBA	2		alpha	LBD	
50-28-2	141	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hanson RN, McCaskill E, Tongcharoensirikul P, Dilis R, Labaree D, Hochberg RB.	STEROIDS	2012	77	471		Binding	relative binding affinity (RBA) of Competitive binding to human LBD-ERa	Human	logRBA	2		alpha	LBD	
50-28-2	142	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay to rat ER alpha expressed in Escherichia coli	Rat	logRBA	2		alpha	LBD	
50-28-2	143	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay to mouse ER alpha expressed in Escherichia coli	Mouse	logRBA	2		alpha	LBD	
50-28-2	144	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Henke BR, Drewry DH, Jones SA, Stewart EL, Weaver SL, Wiethe RW.	Bioorg. Med. Chem. Lett.	2001	11	1939		Binding	Ability to displace [3H]17-beta-estradiol from Estrogen receptor beta by scintillation proximity assay.		logRBA	2		beta		
50-28-2	145	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Smith RA, Chen J, Mader MM, Muegge I, Moehler U, Katti S, Marrero D, Stirtan WG, Weaver DR, Xiao H, Carley W.	Bioorg. Med. Chem. Lett.	2002	12	2875		Binding	Binding affinity for Estrogen receptor beta(ER beta) receptor		logRBA	2		beta		
50-28-2	146	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Binding	Binding affinity towards estrogen receptor beta by [3H]17-beta-estradiol displacement.		logRBA	2		beta		
50-28-2	147	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Compton DR, Carlson KE, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	2004	14	5681		Binding	Binding affinity for Estrogen receptor beta compared to estradiol (100%)		logRBA	2		beta		
50-28-2	148	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mittal S, Durani S, Kapil RS.	J. Med. Chem.	1985	28	492		Binding	Relative binding affinity calculated as the ratio of molar concentration of Estrogen receptor beta and the triarylpropenones (TAP's) required to decrease [3H]E2 binding by 50%.		logRBA	2		beta		
50-28-2	149	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lal K, Sharma I, Agarwal AK, Agnihotri A, Ray S.	J. Med. Chem.	1988	31	1261		Binding	Relative binding affinity(RBA) for Estrogen receptor		logRBA	2		beta		
50-28-2	150	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gantchev TG, Ali H, van Lier JE.	J. Med. Chem.	1994	37	4164		Binding	Relative binding affinity (RBA) towards estrogen receptor.		logRBA	2		beta		
50-28-2	151	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Labaree DC, Zhang JX, Harris HA, OConnor C, Reynolds TY, Hochberg RB.	J. Med. Chem.	2003	46	1886		Binding	Binding affinity against Estrogen receptor with relative to E2		logRBA	2		beta		
50-28-2	152	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Binding	Inhibitory concentration against estrogen receptor 2 using radioligand binding assay.		logRBA	2		beta		
50-28-2	153	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Pigeon P, Top S, VessiÃ¨res A, HuchÃ© M, Hillard EA, Salomon E, Jaouen G.	J. Med. Chem.	2005	48	2814		Binding	Relative binding affinity for Estrogen receptor beta		logRBA	2		beta		
50-28-2	154	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SedlÃ¡k D, NovÃ¡k P, Kotora M, BartÅ¯nek P.	J. Med. Chem.	2010	53	4290		Binding	Ratio of 17-beta-estradiol IC50 to compound IC50 for ERbeta		logRBA	2		beta		
50-28-2	155	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Spradau TW, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	1998	8	3235		Binding	Binding affinity against estrogen receptor was determined by using [3H]estradiol as radioligand in competitive radiometric binding assay		logRBA	2		beta		
50-28-2	156	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Spradau TW, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	1998	8	3235		Binding	Binding affinity against estrogen receptor was determined by using [3H]estradiol as radioligand in competitive radiometric binding assay		logRBA	2		beta		
50-28-2	157	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Miller CP, Jirkovsky I, Tran BD, Harris HA, Moran RA, Komm BS.	Bioorg. Med. Chem. Lett.	2000	10	147		Binding	Displacement of [3H]17-beta-estradiol from human Estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	158	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tedesco R, Youngman MK, Wilson SR, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	2001	11	1281		Binding	Relative binding affinity for human Estrogen receptor beta compared to estradiol (E2)	Human	logRBA	2		beta		
50-28-2	159	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yang C, Edsall R Jr, Harris HA, Zhang X, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2004	12	2553		Binding	solid phase radioligand binding assay of ERb	Human	logRBA	2		beta		
50-28-2	160	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Miller CP, Collini MD, Harris HA.	Bioorg. Med. Chem. Lett.	2003	13	2399		Binding	Binding affinity towards human estrogen receptor beta (ERbeta)	Human	logRBA	2		beta		
50-28-2	161	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sibley R, Hatoum-Mokdad H, Schoenleber R, Musza L, Stirtan W, Marrero D, Carley W, Xiao H, Dumas J.	Bioorg. Med. Chem. Lett.	2003	13	1919		Binding	In vitro binding affinity for estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	162	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tan Q, Birzin ET, Chan W, Tien Yang Y, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3747		Binding	Binding affinity for human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	163	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tan Q, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3753		Binding	Binding affinity for human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	164	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay	Human	logRBA	2		beta		
50-28-2	165	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, DiNinno F, Morgan JD 2nd, Chen HY, Wu JY, Gude C, Kim S, Chan W, Birzin ET, Tien Yang Y, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3861		Binding	Binding potency for human ER beta	Human	logRBA	2		beta		
50-28-2	166	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, DiNinno F, Morgan JD 2nd, Wu JY, Chen HY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3865		Binding	Binding potency for human ER beta	Human	logRBA	2		beta		
50-28-2	167	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Collini MD, Kaufman DH, Manas ES, Harris HA, Henderson RA, Xu ZB, Unwalla RJ, Miller CP.	Bioorg. Med. Chem. Lett.	2004	14	4925		Binding	Binding affinity for human Estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	168	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Tan Q, Blizzard TA, Morgan JD 2nd, Birzin ET, Chan W, Yang YT, Pai LY, Hayes EC, DaSilva CA, Warrier S, Yudkovitz J, Wilkinson HA, Sharma N, Fitzgerald PM, Li S, Colwell L, Fisher JE, Adamski S, Reszka AA, Kimmel D, DiNinno F, Rohrer SP, Freedman LP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	1675		Binding	Inhibition of estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	169	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Liu J, Birzin ET, Chan W, Yang YT, Pai LY, Dasilva C, Hayes EC, Mosley RT, Dininno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	715		Binding	Binding affinity for human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	170	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Dininno F, Morgan JD 2nd, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PM, Sharma N, Li Y, Zhang Z, Hayes EC, Dasilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	107		Binding	Inhibition of binding to recombinant human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	171	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA.	Bioorg. Med. Chem. Lett.	2005	15	3137		Binding	Inhibition of human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	172	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2005	15	4520		Binding	Binding affinity for human Estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	173	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Chesworth R, Wessel MD, Heyden L, Mangano FM, Zawistoski M, Gegnas L, Galluzzo D, Lefker B, Cameron KO, Tickner J, Lu B, Castleberry TA, Petersen DN, Brault A, Perry P, Ng O, Owen TA, Pan L, Ke HZ, Brown TA, Thompson DD, DaSilva-Jardine P.	Bioorg. Med. Chem. Lett.	2005	15	5562		Binding	Displacement of [3H]17beta-estradiol from recombinant human ERbeta expressed in 293T cells	Human	logRBA	2		beta		
50-28-2	174	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Gude C, Morgan JD 2nd, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Sharma N, Fitzgerald PM, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2006	16	834		Binding	Binding affinity to human ERbeta	Human	logRBA	2		beta		
50-28-2	175	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sun W, Cama LD, Birzin ET, Warrier S, Locco L, Mosley R, Hammond ML, Rohrer SP.	Bioorg. Med. Chem. Lett.	2006	16	1468		Binding	Binding affinity to ERbeta	Human	logRBA	2		beta		
50-28-2	176	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML, Mosley RT, Fitzgerald PM, Sharma N, McKeever BM, Nilsson S, Carlquist M, Thorsell A, Locco L, Katz R, Frisch K, Birzin ET, Wilkinson HA, Mitra S, Cai S, Hayes EC, Schaeffer JM, Rohrer SP.	Bioorg. Med. Chem. Lett.	2006	16	3489		Binding	Binding affinity to ERbeta by scintillation proximity assay	Human	logRBA	2		beta		
50-28-2	177	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Wilkening RR, Ratcliffe RW, Fried AK, Meng D, Sun W, Colwell L, Lambert S, Greenlee M, Nilsson S, Thorsell A, Mojena M, Tudela C, Frisch K, Chan W, Birzin ET, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2006	16	3896		Binding	Binding affinity to human ERbeta	Human	logRBA	2		beta		
50-28-2	178	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Parker DL Jr, Meng D, Ratcliffe RW, Wilkening RR, Sperbeck DM, Greenlee ML, Colwell LF, Lambert S, Birzin ET, Frisch K, Rohrer SP, Nilsson S, Thorsell AG, Hammond ML.	Bioorg. Med. Chem. Lett.	2006	16	4652		Binding	Binding affinity to human recombinant ERbeta by scintillation proximity assay	Human	logRBA	2		beta		
50-28-2	179	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST.	Bioorg. Med. Chem. Lett.	2007	17	902		Binding	Inhibition of human ERbeta by radioligand binding assay	Human	logRBA	2		beta		
50-28-2	180	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Gude C, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Holmes MA, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2007	17	2944		Binding	Binding affinity to human recombinant ERbeta by scintillation proximity assay	Human	logRBA	2		beta		
50-28-2	181	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Vu AT, Campbell AN, Harris HA, Unwalla RJ, Manas ES, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	4053		Binding	Inhibition of human ERbeta	Human	logRBA	2		beta		
50-28-2	182	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, Gude C, Morgan JD 2nd, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2007	17	6295		Binding	Binding affinity at human recombinant ERbeta	Human	logRBA	2		beta		
50-28-2	183	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ohta K, Chiba Y, Ogawa T, Endo Y.	Bioorg. Med. Chem. Lett.	2008	18	5050		Binding	Binding affinity to human recombinant ERbeta receptor by liquid scintillation counter	Human	logRBA	2		beta		
50-28-2	184	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	1999	42	2456		Binding	Binding affinity for human ER(estrogen receptor)beta	Human	logRBA	2		beta		
50-28-2	185	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Bertini S, Papi C, Carlson KE, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2001	44	4288		Binding	Relative binding affinity for human estrogen receptor beta by displacement of [3H]estradiol	Human	logRBA	2		beta		
50-28-2	186	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta.	Human	logRBA	2		beta		
50-28-2	187	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Antonello M, Bertini S, Ortore G, Placanica G, Rapposelli S, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2003	46	4032		Binding	Relative binding affinity  for human estrogen receptor betacompared to [3H]-estradiol	Human	logRBA	2		beta		
50-28-2	188	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Nussbaumer P, Winiski AP, Billich A.	J. Med. Chem.	2003	46	5091		Binding	Affinity of compound towards human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	189	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY, Yang YT, Mosley RT, Fitzgerald PM, Sharma N, Dahllund J, Thorsell AG, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	J. Med. Chem.	2004	47	2171		Binding	Binding affinity towards human recombinant Estrogen receptor beta was determined	Human	logRBA	2		beta		
50-28-2	190	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mewshaw RE, Edsall RJ Jr, Yang C, Manas ES, Xu ZB, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2005	48	3953		Binding	Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor beta expressed in Escherichia coli	Human	logRBA	2		beta		
50-28-2	191	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Binding	Inhibition of [3H]estradiol binding to human estrogen receptor beta expressed in HeLa cells	Human	logRBA	2		beta		
50-28-2	192	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hoekstra WJ, Patel HS, Liang X, Blanc JB, Heyer DO, Willson TM, Iannone MA, Kadwell SH, Miller LA, Pearce KH, Simmons CA, Shearin J.	J. Med. Chem.	2005	48	2243		Binding	Binding affinity for human estrogen receptor beta	Human	logRBA	2		beta		
50-28-2	193	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Binding	Binding affinity towards human estrogen receptor beta in a competitive binding assay using fluorescently labelled estradiol; relative to 4-hydroxytamoxifen, (normalized to E2)	Human	logRBA	2		beta		
50-28-2	194	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yoo J, Dence CS, Sharp TL, Katzenellenbogen JA, Welch MJ.	J. Med. Chem.	2005	48	6366		Binding	Relative binding affinity for human estrogen receptor beta using [3H]estradiol upon incubation at 0 degree C for 18-24 h	Human	logRBA	2		beta		
50-28-2	195	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	GÃ¼ngr T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.	J. Med. Chem.	2006	49	2440		Binding	Displacement of [3H]estrone from ER beta	Human	logRBA	2		beta		
50-28-2	196	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kinzel O, Fattori D, Muraglia E, Gallinari P, Nardi MC, Paolini C, Roscilli G, Toniatti C, Gonzalez Paz O, Laufer R, Lahm A, Tramontano A, Cortese R, De Francesco R, Ciliberto G, Koch U.	J. Med. Chem.	2006	49	5404		Binding	Binding affinity to human ER beta	Human	logRBA	2		beta		
50-28-2	197	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Zhao L, Jin C, Mao Z, Gopinathan MB, Rehder K, Brinton RD.	J. Med. Chem.	2007	50	4471		Binding	Binding affinity to human ERbeta	Human	logRBA	2		beta		
50-28-2	198	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Djiogue S, Halabalaki M, Alexi X, Njamen D, Fomum ZT, Alexis MN, Skaltsounis AL.	J. Nat. Prod.	2009	72	1603		Binding	Displacement of fluorescent estrogen ES2 from human recombinant ERbeta by fluorescence polarization assay relative to 17-beta-estradiol	Human	logRBA	2		beta		
50-28-2	199	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sadek SA, Kessler WV, Shaw SM, Anderson JN, Wolf GC.	J. Med. Chem.	1982	25	1488		Binding	Relative binding affinity against Estrogen receptor as inhibition of [3H]estradiol binding in rat uterus	Rat	logRBA	2		beta		
50-28-2	200	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Bagley JR, Nanavati NT.	J. Med. Chem.	1988	31	1471		Binding	In vitro displacement of [3H]estradiol from estrogen receptor of rat uterine cystol	Rat	logRBA	2		beta		
50-28-2	201	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Bagley JR, Nanavati NT.	J. Med. Chem.	1988	31	1471		Binding	In vitro relative binding affinity for estrogen receptorin rat uterine cytosol by displacement of [3H]estradiol	Rat	logRBA	2		beta		
50-28-2	202	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]-estradiol from estrogen receptor in mature rat	Rat	logRBA	2		beta		
50-28-2	203	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]-estradiol from estrogen receptor in immature rat	Rat	logRBA	2		beta		
50-28-2	204	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hanson RN, Napolitano E, Fiaschi R.	J. Med. Chem.	1990	33	3155		Binding	Relative binding affinity for rat uterine estrogen receptor at 0C	Rat	logRBA	2		beta		
50-28-2	205	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hanson RN, Napolitano E, Fiaschi R.	J. Med. Chem.	1990	33	3155		Binding	Relative binding affinity for rat uterine estrogen receptor at 25 degree C	Rat	logRBA	2		beta		
50-28-2	206	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Saeed A, Sharma AP, Durani N, Jain R, Durani S, Kapil RS.	J. Med. Chem.	1990	33	3210		Binding	Relative binding affinity for estrogen receptor(ER)	Rat	logRBA	2		beta		
50-28-2	207	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA.	J. Med. Chem.	1990	33	3143		Binding	Binding affinity against estrogen receptor at 25 degree C	Rat	logRBA	2		beta		
50-28-2	208	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA.	J. Med. Chem.	1990	33	3143		Binding	Binding affinity against estrogen receptor at 0C	Rat	logRBA	2		beta		
50-28-2	209	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Levesque C, Merand Y, Dufour JM, Labrie C, Labrie F.	J. Med. Chem.	1991	34	1624		Binding	Relative binding affinity for estrogen receptor from immature rat uterus	Rat	logRBA	2		beta		
50-28-2	210	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Day BW, Magarian RA, Jain PT, Pento JT, Mousissian GK, Meyer KL.	J. Med. Chem.	1991	34	842		Binding	Relative binding affinity evaluated from the ability to displace [3H]estradiol from estrogen receptor in rat uterine cytosol preparation.	Rat	logRBA	2		beta		
50-28-2	211	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ.	J. Med. Chem.	1993	36	1619		Binding	Relative binding affinity for estrogen receptor at 0C	Rat	logRBA	2		beta		
50-28-2	212	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ.	J. Med. Chem.	1993	36	1619		Binding	Relative binding affinity for estrogen receptor at 25 degree C	Rat	logRBA	2		beta		
50-28-2	213	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ray S, Tandon A, Dwivedy I, Wilson SR, ONeil JP, Katzenellenbogen JA.	J. Med. Chem.	1994	37	696		Binding	Percent affinity for estrogen receptor binding relative to d-estradiol	Rat	logRBA	2		beta		
50-28-2	214	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hoyte RM, Borderon K, Bryson K, Allen R, Hochberg RB, Brown TJ.	J. Med. Chem.	1994	37	1224		Binding	Relative binding affinity for estrogen receptor in rat uterine cystosol extract	Rat	logRBA	2		beta		
50-28-2	215	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Bourne CS, Sullivan KJ, Moore SA.	J. Med. Chem.	1996	39	4853		Binding	Displacement of [3H]- Estradiol from Estrogen receptor of rat uterine cytosol	Rat	logRBA	2		beta		
50-28-2	216	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Rosati RL, Da Silva Jardine P, Cameron KO, Thompson DD, Ke HZ, Toler SM, Brown TA, Pan LC, Ebbinghaus CF, Reinhold AR, Elliott NC, Newhouse BN, Tjoa CM, Sweetnam PM, Cole MJ, Arriola MW, Gauthier JW, Crawford DT, Nickerson DF, Pirie CM, Qi H, Simmons HA, Tkalcevic GT.	J. Med. Chem.	1998	41	2928		Binding	Inhibition of estradiol binding to estrogen receptor	Rat	logRBA	2		beta		
50-28-2	217	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		Bioorg. Med. Chem. Lett.	1995	5	839		Binding	Relative binding affinity against estrogen receptor of rat uterine tissue was determined relative to estradiol	Rat	logRBA	2		beta		
50-28-2	218	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		Bioorg. Med. Chem. Lett.	1996	6	1747		Binding	Binding affinity for rat uterine estrogen receptor	Rat	logRBA	2		beta		
50-28-2	219	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Sadler BR, Cho SJ, Ishaq KS, Chae K, Korach KS.	J. Med. Chem.	1998	41	2261		Binding	Relative binding affinity ( relative to estradiol) to mouse estrogen receptor.	Mouse	logRBA	2		beta		
50-28-2	220	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		Bioorg. Med. Chem. Lett.	1995	5	133		Binding	Binding affinity for mouse uterine cytosol estrogen receptor	Mouse	logRBA	2		beta		
50-28-2	221	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ouellet R, Rousseau J, Brasseur N, van Lier JE, Diksic M, Westera G.	J. Med. Chem.	1984	27	509		Binding	Relative binding affinity for estrogen receptor by displacement of [3H]estradiol	Cattle	logRBA	2		beta		
50-28-2	222	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Binding	Relative binding affinity against estrogen receptor in calf uterus cytosol using [3H]E2 as radioligand, incubated at 2 hours at 0 degree Centigrade.	Cattle	logRBA	2		beta		
50-28-2	223	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Binding	Relative binding affinity against estrogen receptor in calf uterus cytosol using [3H]E2 as radioligand, incubated at 5 hours at 25 degree Centigrade.	Cattle	logRBA	2		beta		
50-28-2	224	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Knebel NG, von Angerer E.	J. Med. Chem.	1991	34	2145		Binding	Binding affinity towards calf uterine estrogen receptor using [3H]17-beta-estradiol as radioligand	Cattle	logRBA	2		beta		
50-28-2	225	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	DorÃ© JC, Gilbert J, Bignon E, Crastes de Paulet A, Ojasoo T, Pons M, Raynaud JP, Miquel JF.	J. Med. Chem.	1992	35	573		Binding	Relative binding affinity was measured on calf uterus estrogen receptor after 5 hr at 25C.	Cattle	logRBA	2		beta		
50-28-2	226	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gust R, Keilitz R, Schmidt K, von Rauch M.	J. Med. Chem.	2002	45	3356		Binding	Relative binding affinity (RBA) to Estrogen receptor of calf uterine cytosol	Cattle	logRBA	2		beta		
50-28-2	227	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	2		beta	Full-length	
50-28-2	228	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERb binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	2		beta	Full-length	
50-28-2	229	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Blizzard TA, DiNinno F, Chen HY, Kim S, Wu JY, Chan W, Birzin ET, Yang YT, Pai LY, Hayes EC, DaSilva CA, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	3912		Binding	human estrogen receptor beta binding using scintillation proximity assay	Human	logRBA	2		beta	Full-length	
50-28-2	230	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Dykstra KD, Guo L, Birzin ET, Chan W, Yang YT, Hayes EC, DaSilva CA, Pai LY, Mosley RT, Kraker B, Fitzgerald PM, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2007	17	2322		Binding	Displacement of [3H]estradiol from full length human recombinant ERbeta after 3 hrs by scintillation proximity assay	Human	logRBA	2		beta	Full-length	
50-28-2	231	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Fang J, Akwabi-Ameyaw A, Britton JE, Katamreddy SR, Navas F 3rd, Miller AB, Williams SP, Gray DW, Orband-Miller LA, Shearin J, Heyer D.	Bioorg. Med. Chem. Lett.	2008	18	5075		Binding	Displacement of [3H]estradiol from full length biotinylated human ERbeta by scintillation proximity assay	Human	logRBA	2		beta	Full-length	
50-28-2	232	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Binding	Relative binding affinity (RBA) at human estrogen receptor beta (radiometric binding assay with [3H]estradiol using full-length human ER Beta)	Human	logRBA	2		beta	Full-length	
50-28-2	233	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	2012	55	528		Binding	Relative Ligand Binding Affinities for ERb	Human	logRBA	2		beta	Full-length	
50-28-2	234	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	2		beta	Full-length	
50-28-2	235	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	2		beta	Full-length	
50-28-2	236	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2		beta	Full-length	
50-28-2	237	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2		beta	Full-length	
50-28-2	238	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	2		beta	Full-length	
50-28-2	239	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	2		beta	Full-length	
50-28-2	240	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2003	11	3457		Binding	solid phase radioligand binding assay of ERb	Human	logRBA	2		beta	LBD	
50-28-2	241	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ullrich JW, Unwalla RJ, Singhaus RR Jr, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	118		Binding	Inhibition of human LBD of ERbeta	Human	logRBA	2		beta	LBD	
50-28-2	242	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Labaree DC, Zhang JX, Harris HA, OConnor C, Reynolds TY, Hochberg RB.	J. Med. Chem.	2003	46	1886		Binding	Binding of [3H]E2 alkyl ester to human estrogen receptor beta ligand binding domain expressed in Escherichia coli	Human	logRBA	2		beta	LBD	
50-28-2	243	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay against human ER beta expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand	Human	logRBA	2		beta	LBD	
50-28-2	244	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Roelens F, Heldring N, Dhooge W, Bengtsson M, Comhaire F, Gustafsson JA, Treuter E, De Keukeleire D.	J. Med. Chem.	2006	49	7357		Binding	Displacement of [3H]E2 from human recombinant ERbeta LBD by SPA	Human	logRBA	2		beta	LBD	
50-28-2	245	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SchÃ¤fer A, Wellner A, Gust R.	CHEMMEDCHEM	2011	6	794		Binding	Relative binding affinities (RBA) at hERb as determined by HAP assay	Human	logRBA	2		beta	LBD	
50-28-2	246	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay to rat ER beta expressed in Escherichia coli	Rat	logRBA	2		beta	LBD	
50-28-2	247	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay to mouse ER beta expressed in Escherichia coli	Mouse	logRBA	2		beta	LBD	
50-28-2	248	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	2				
50-28-2	249	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	2				
50-28-2	250	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERa	Human	logRA	2				
50-28-2	251	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gaido KW, Leonard LS, Lovell S, Gould JC, BabaÃ¯ D, Portier CJ, McDonnell DP.	Toxicol. Appl. Pharmacol.	1997	143	205		Reporter Gene	Relative Potency Ratios (RPR) for Yeast based ER Gene Transcription Assay	Human	logRA	2				
50-28-2	252	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Gilbert NE, Liberto MM, Sharp DW, Lin YC, Brueggemeier RW.	J. Med. Chem.	1996	39	1917		Reporter Gene	Induction of pS2 mR expression in human MCF-7 mammary carcinoma cells	Human	logRA	2				
50-28-2	253	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Gilbert NE, Liberto MM, Sharp DW, Lin YC, Brueggemeier RW.	J. Med. Chem.	1996	39	1917		Reporter Gene	Induction of pS2 mR expression in human MCF-7 mammary carcinoma cells	Human	logRA	2				
50-28-2	254	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gust R, Keilitz R, Schmidt K, von Rauch M.	J. Med. Chem.	2002	45	3356		Reporter Gene	Percent relative activation of luciferase expression in MCF-7-2a cells at a concentration of 1 uM	Human	logRA	2				
50-28-2	255	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Gust R, Keilitz R, Schmidt K, von Rauch M.	J. Med. Chem.	2002	45	3356		Reporter Gene	Agonist activity in transcriptional activation assay in MCF-7-2a cells compared to estradiol E2	Human	logRA	2				
50-28-2	256	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SchÃ¤fer A, Wellner A, Gust R.	CHEMMEDCHEM	2011	6	794		Reporter Gene	reporter gene assay of inhibitory potential on MCF-7/2a	Human	logRA	2				
50-28-2	257	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SchÃ¤fer A, Wellner A, Gust R.	CHEMMEDCHEM	2011	6	794		Reporter Gene	reporter gene assay of inhibitory potential on US-OS/a	Human	logRA	2				
50-28-2	258	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	SchÃ¤fer A, Wellner A, Gust R.	CHEMMEDCHEM	2011	6	794		Reporter Gene	reporter gene assay of inhibitory potential on US-OS/b	Human	logRA	2				
50-28-2	259	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	De Naeyer A, Vanden Berghe W, Pocock V, Milligan S, Haegeman G, De Keukeleire D.	J. Nat. Prod.	2004	67	1829		Reporter Gene	Estrogenic activity at human estrogen receptor expressing Saccharomyces cerevisiae carrying estrogen responsive sequence contatining plasmid assessed as metabolism of chlorophenol res beta-D-galactopyranoside	Human	logRA	2				
50-28-2	260	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	De Naeyer A, Vanden Berghe W, Pocock V, Milligan S, Haegeman G, De Keukeleire D.	J. Nat. Prod.	2004	67	1829		Reporter Gene	Estrogenic activity at estrogen receptor in human Ishikawa Var-1 cells assessed as stimulation of alkaline phosphatase activity measured by metabolism of p-nitrophenol phosphatase after 72 hrs	Human	logRA	2				
50-28-2	261	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERb	Rat	logRA	2				
50-28-2	262	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Reporter Gene	Ability to activate estrogen receptor 1-mediated transcription.		logRA	2		alpha		
50-28-2	263	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Roberts LR, Armor D, Barker C, Bent A, Bess K, Brown A, Favor DA, Ellis D, Irving SL, MacKenny M, Phillips C, Pullen N, Stennett A, Strand L, Styles M.	Bioorg. Med. Chem. Lett.	2011	21	5680		Reporter Gene	Agonist activity at ERalpha expressed in HEK cells co-expressing beta-lactamase after 18 hrs by beta-lactamase reporter gene assay		logRA	2		alpha		
50-28-2	264	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Agonist activity at ERalpha expressed in yeast assessed as alpha-galactosidase activity		logRA	2		alpha		
50-28-2	265	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Agonist activity at ERalpha expressed in yeast assessed as alpha-galactosidase activity relative to E2		logRA	2		alpha		
50-28-2	266	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Agonist activity at ERalpha expressed in CHO-K1 cells by luciferase reporter gene transactivation assay		logRA	2		alpha		
50-28-2	267	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Miller CP, Jirkovsky I, Tran BD, Harris HA, Moran RA, Komm BS.	Bioorg. Med. Chem. Lett.	2000	10	147		Reporter Gene	Agonist effect on transcriptional activation in MCF-7 cells expressing estrogen receptor alpha	Human	logRA	2		alpha		
50-28-2	268	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hamann LG, Meyer JH, Ruppar DA, Marschke KB, Lopez FJ, Allegretto EA, Karanewsky DS.	Bioorg. Med. Chem. Lett.	2005	15	1463		Reporter Gene	In vitro agonist activity for estrogen receptor alpha expressed in COS-1 cells	Human	logRA	2		alpha		
50-28-2	269	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Gilbert NE, Liberto MM, Sharp DW, Lin YC, Brueggemeier RW.	J. Med. Chem.	1996	39	1917		Reporter Gene	Relative induction of pS2 mR expression in human MCF-7 mammary carcinoma cells compared to estradiol	Human	logRA	2		alpha		
50-28-2	270	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Bhat AS, Coughenour HD, Gilbert NE, Brueggemeier RW.	J. Med. Chem.	1997	40	3756		Reporter Gene	Induction of pS2 Gene expression in human MCF-7 cells	Human	logRA	2		alpha		
50-28-2	271	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Lovely CJ, Bhat AS, Coughenour HD, Gilbert NE, Brueggemeier RW.	J. Med. Chem.	1997	40	3756		Reporter Gene	Induction of pS2 gene expression in human MCF-7 cells	Human	logRA	2		alpha		
50-28-2	272	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Transcriptional potency (EC50) at Human estrogen receptor alpha	Human	logRA	2		alpha		
50-28-2	273	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Relative estrogenic potency at Human estrogen receptor alpha (EC50 (Estradiol) / EC50 (ligand))	Human	logRA	2		alpha		
50-28-2	274	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Waibel M, De Angelis M, Stossi F, Kieser KJ, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	Eur. J. Med. Chem.	2009	44	3412		Reporter Gene	Agonist activity at ERalpha expressed in human HEC1 cells assessed as transcriptional potency after 24 hrs by luciferase-beta galactosidase reporter gene assay	Human	logRA	2		alpha		
50-28-2	275	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.	Human	logRA	2		alpha		
50-28-2	276	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Reporter Gene	Agonist effect on transcriptional activation in T47D cells expressing estrogen receptor alpha	Human	logRA	2		alpha		
50-28-2	277	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Reporter Gene	Percent of maximal transcriptional activation in T47D cells expressing estrogen receptor alpha compared to 17-beta-estradiol	Human	logRA	2		alpha		
50-28-2	278	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2005	48	1132		Reporter Gene	Transcriptional efficacy against human estrogen receptor alpha at 10e-8 M	Human	logRA	2		alpha		
50-28-2	279	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2005	48	1132		Reporter Gene	Transcriptional efficacy against human estrogen receptor alpha at 10e-6 M	Human	logRA	2		alpha		
50-28-2	280	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Transcriptional activation of estrogen receptor alpha in U2OS cell using estrogen-regulated luciferase reporter gene plasmid upon incubation for 20-30 mins at RT	Human	logRA	2		alpha		
50-28-2	281	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Transcriptional activation of estrogen receptor alpha in U2OS cell using estrogen-regulated luciferase reporter gene plasmid upon incubation for 20-30 mins at RT	Human	logRA	2		alpha		
50-28-2	282	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mcklinghoff S, van Otterlo WA, Rose R, Fuchs S, Zimmermann TJ, Dominguez Seoane M, Waldmann H, Ottmann C, Brunsveld L.	J. Med. Chem.	2011	54	2005		Reporter Gene	Agonist activity at human N-terminal His6-tagged ERalpha receptor LBD expressed in Escherichia coli BL21 (DE3) assessed as induction of SRC1 peptide recruitment after 1 hr by fluorescence polarization assay	Human	logRA	2		alpha		
50-28-2	283	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Bertini S, De Cupertinis A, Granchi C, Bargagli B, Tuccinardi T, Martinelli A, Macchia M, Gunther JR, Carlson KE, Katzenellenbogen JA, Minutolo F.	Eur. J. Med. Chem.	2011	46	2453		Reporter Gene	Agonist activity at human full-length ERalpha receptor expressed in human HEC1 cells co-expressing (ERE)2-pS2-luc gene assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay	Human	logRA	2		alpha	Full-length	
50-28-2	284	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2009	52	858		Reporter Gene	Agonist activity at full-length human estrogen receptor alpha expressed in human HEC1 cells assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay	Human	logRA	2		alpha	Full-length	
50-28-2	285	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR.	J. Nat. Prod.	2009	72	1944		Reporter Gene	Agonist activity at estrogen receptor alpha ligand binding domain expressed in african green monkey COS7 cells cotransfected with Gal4-LBD by luciferase reporter gene assay		logRA	2		alpha	LBD	
50-28-2	286	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	2		alpha	LBD	
50-28-2	287	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Reporter Gene	Ability to activate estrogen receptor 2-mediated transcription.		logRA	2		beta		
50-28-2	288	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Hamann LG, Meyer JH, Ruppar DA, Marschke KB, Lopez FJ, Allegretto EA, Karanewsky DS.	Bioorg. Med. Chem. Lett.	2005	15	1463		Reporter Gene	In vitro agonist activity for estrogen receptor beta expressed in COS-1 cells		logRA	2		beta		
50-28-2	289	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Roberts LR, Armor D, Barker C, Bent A, Bess K, Brown A, Favor DA, Ellis D, Irving SL, MacKenny M, Phillips C, Pullen N, Stennett A, Strand L, Styles M.	Bioorg. Med. Chem. Lett.	2011	21	5680		Reporter Gene	Agonist activity at ERbeta expressed in UAS cells co-expressing beta-lactamase after 18 hrs by beta-lactamase reporter gene assay		logRA	2		beta		
50-28-2	290	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Agonist activity at ERbeta expressed in CHO-K1 cells by luciferase reporter gene transactivation assay		logRA	2		beta		
50-28-2	291	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Agonist activity at ERbeta expressed in yeast assessed as alpha-galactosidase activity relative to E2		logRA10	2		beta		
50-28-2	292	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Transcriptional potency (EC50) at Human estrogen receptor Beta	Human	logRA	2		beta		
50-28-2	293	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Relative estrogenic potency at Human estrogen receptor Beta (EC50 (Estradiol) / EC50 (ligand))	Human	logRA	2		beta		
50-28-2	294	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Waibel M, De Angelis M, Stossi F, Kieser KJ, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	Eur. J. Med. Chem.	2009	44	3412		Reporter Gene	Agonist activity at ERbeta expressed in human HEC1 cells assessed as transcriptional potency after 24 hrs by luciferase-beta galactosidase reporter gene assay	Human	logRA	2		beta		
50-28-2	295	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.	Human	logRA	2		beta		
50-28-2	296	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta	Human	logRA	2		beta		
50-28-2	297	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Reporter Gene	Agonist effect on transcriptional activation of T47D cells expressing human estrogen receptor beta	Human	logRA	2		beta		
50-28-2	298	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Reporter Gene	Percent of maximal transcriptional activation in T47D cells expressing estrogen receptor beta compared to 17-beta-estradiol	Human	logRA	2		beta		
50-28-2	299	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2005	48	1132		Reporter Gene	Transcriptional efficacy against human estrogen receptor beta at 10e-8 M	Human	logRA	2		beta		
50-28-2	300	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2005	48	1132		Reporter Gene	Transcriptional efficacy against human estrogen receptor beta at 10e-6 M	Human	logRA	2		beta		
50-28-2	301	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Transcriptional activation of estrogen receptor beta in U2OS cell using estrogen-regulated luciferase reporter gene plasmid upon incubation for 20-30 mins at RT	Human	logRA	2		beta		
50-28-2	302	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Transcriptional activation of estrogen receptor beta in U2OS cell using estrogen-regulated luciferase reporter gene plasmid upon incubation for 20-30 mins at RT	Human	logRA	2		beta		
50-28-2	303	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Patch RJ, Searle LL, Kim AJ, De D, Zhu X, Askari HB, ONeill JC, Abad MC, Rentzeperis D, Liu J, Kemmerer M, Lin L, Kasturi J, Geisler JG, Lenhard JM, Player MR, Gaul MD.	J. Med. Chem.	2011	54	788		Reporter Gene	Agonist activity at human ERbeta LBD by cell based luciferase reporter gene assay	Human	logRA	2		beta		
50-28-2	304	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Mcklinghoff S, van Otterlo WA, Rose R, Fuchs S, Zimmermann TJ, Dominguez Seoane M, Waldmann H, Ottmann C, Brunsveld L.	J. Med. Chem.	2011	54	2005		Reporter Gene	Agonist activity at human N-terminal His6-tagged ERbeta receptor LBD expressed in Escherichia coli BL21 (DE3) assessed as induction of SRC1 peptide recruitment after 1 hr by fluorescence polarization assay	Human	logRA	2		beta		
50-28-2	305	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Bertini S, De Cupertinis A, Granchi C, Bargagli B, Tuccinardi T, Martinelli A, Macchia M, Gunther JR, Carlson KE, Katzenellenbogen JA, Minutolo F.	Eur. J. Med. Chem.	2011	46	2453		Reporter Gene	Agonist activity at human full-length ERbeta receptor expressed in human HEC1 cells co-expressing (ERE)2-pS2-luc gene assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay	Human	logRA	2		beta	Full-length	
50-28-2	306	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Minutolo F, Bertini S, Granchi C, Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther JR, Carlson KE, Katzenellenbogen JA, Macchia M.	J. Med. Chem.	2009	52	858		Reporter Gene	Agonist activity at full-length human estrogen receptor beta expressed in human HEC1 cells assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay	Human	logRA	2		beta	Full-length	
50-28-2	307	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Agonist activity at ERbeta expressed in yeast assessed as alpha-galactosidase activity		logRA	2		beta	LBD	
50-28-2	308	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR.	J. Nat. Prod.	2009	72	1944		Reporter Gene	Agonist activity at estrogen receptor beta ligand binding domain expressed in african green monkey COS7 cells cotransfected with Gal4-LBD by luciferase reporter gene assay		logRA	2		beta	LBD	
50-28-2	309	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ohta K, Chiba Y, Ogawa T, Endo Y.	Bioorg. Med. Chem. Lett.	2008	18	5050		Cell Proliferation	Estrogenic activity in human MCF7 cells assessed as cell proliferation after 6 days by WST8 assay	Human	logRE	2				
50-28-2	310	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Cell Proliferation	Percent of effective dose for [3H]estradiol against proliferation of MCF-7 cells.	Human	logRE	2				
50-28-2	311	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	DorÃ© JC, Gilbert J, Bignon E, Crastes de Paulet A, Ojasoo T, Pons M, Raynaud JP, Miquel JF.	J. Med. Chem.	1992	35	573		Cell Proliferation	Agonistic activity in MCF-7 cell proliferation.	Human	logRE	2				
50-28-2	312	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Bourne CS, Sullivan KJ, Moore SA.	J. Med. Chem.	1996	39	4853		Cell Proliferation	Effect on estradiol-stimulated MCF-7 cell proliferation	Human	logRE	2				
50-28-2	313	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Ruenitz PC, Bourne CS, Sullivan KJ, Moore SA.	J. Med. Chem.	1996	39	4853		Cell Proliferation	Stimulation of MCF-7 cell proliferation	Human	logRE	2				
50-28-2	314	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Wiese TE, Polin LA, Palomino E, Brooks SC.	J. Med. Chem.	1997	40	3659		Cell Proliferation	Growth response in cultures of MCF-7 (human breast cancer cell line) cells	Human	logRE	2				
50-28-2	315	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Cell Proliferation	Percent agonistic activity in MCF-7 breast tumor cells using MCF-7 assay	Human	logRE	2				
50-28-2	316	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Cell Proliferation	Percent agonist activity against human breast adenocarcinoma (MCF-7) cell proliferation	Human	logRE	2				
50-28-2	317	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Maximov PY, Myers CB, Curpan RF, Lewis-Wambi JS, Jordan VC.	J. Med. Chem.	2010	53	3273		Cell Proliferation	Estrogenic activity in human ERalpha expressing MCF7:WS8 cells assessed as stimulation of cell proliferation after 7 days	Human	logRE	2				
50-28-2	318	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Patch RJ, Searle LL, Kim AJ, De D, Zhu X, Askari HB, ONeill JC, Abad MC, Rentzeperis D, Liu J, Kemmerer M, Lin L, Kasturi J, Geisler JG, Lenhard JM, Player MR, Gaul MD.	J. Med. Chem.	2011	54	788		Cell Proliferation	Agonist activity at human ERalpha LBD in human MCF7 cells assessed as induction of cell proliferation after up to 6 days by celltiter-glo assay	Human	logRE	2				
50-28-2	319	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO.	Environ. Health Perspect. 	1995	103	113		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	2				
50-28-2	320	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	2				
50-28-2	321	1	estradiol	C18H24O2	272.38	3.74		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	2.53				Sc
10540-29-1	322	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Halabalaki M, Aligiannis N, Papoutsi Z, Mitakou S, Moutsatsou P, Sekeris C, Skaltsounis AL.	J. Nat. Prod.	2000	63	1672		Binding	Displacement of [3H]estradiol from estrogen receptor relative to estradiol		logRBA	-0.161				
10540-29-1	323	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	0				
10540-29-1	324	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cells	Human	logRBA	-1.222				
10540-29-1	325	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kumar S, Deshpande S, Chandra V, Kitchlu S, Dwivedi A, Nayak VL, Konwar R, Prabhakar YS, Sahu DP.	Bioorg. Med. Chem.	2009	17	6832		Binding	Displacement of [3H]estradiol from rat estrogen receptor by radiometric assay relative to estradiol	Rat	logRBA	0.367				
10540-29-1	326	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kumar A, Tripathi VD, Kumar P, Gupta LP, Akanksha, Trivedi R, Bid H, Nayak VL, Siddiqui JA, Chakravarti B, Saxena R, Dwivedi A, Siddiquee MI, Siddiqui U, Konwar R, Chattopadhyay N.	Bioorg. Med. Chem.	2011	19	5409		Binding	Displacement of [3H]-estradiol from estrogen receptor in rat uteri after 18 hrs by scintillation counting relative to 17beta-estradiol	Rat	logRBA	0.342				
10540-29-1	327	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	0.126				
10540-29-1	328	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Mouse uterine cytosol	Mouse	logRBA	0.816				
10540-29-1	329	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	1.398			LBD	
10540-29-1	330	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	1.204			LBD	
10540-29-1	331	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	1			LBD	
10540-29-1	332	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Adamczyk M, Reddy RE, Yu Z.	Bioorg. Med. Chem. Lett.	2002	12	1283		Binding	Displacement of radioligand from Estrogen receptor alpha		logRBA	1.607		alpha		
10540-29-1	333	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		Bioorg. Med. Chem. Lett.	1995	5	2217		Binding	Relative binding affinity (RBA) for estrogen receptor compared to estradiol		logRBA	0.114		alpha		
10540-29-1	334	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		Bioorg. Med. Chem. Lett.	1997	7	887		Binding	Affinity against estrogen receptor in MCF-7 cell lysate by competitive displacement of [3H]estradiol		logRBA	0		alpha		
10540-29-1	335	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Binding	Binding affinity for estrogen receptor, by competition with [3H]estradiol		logRBA	-1.387		alpha		
10540-29-1	336	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Meegan MJ, Hughes RB, Lloyd DG, Williams DC, Zisterer DM.	J. Med. Chem.	2001	44	1072		Binding	Binding affinity for estrogen receptor	Human	Ki	157	nM	alpha		
10540-29-1	337	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Binding	Displacement of fluorescein labeled estradiol from human recombinant ERalpha expressed in baculovirus infected insect cells by fluorescence polarization assay	Human	IC50	70	nM	alpha		
10540-29-1	338	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kraft KS, Ruenitz PC, Bartlett MG.	J. Med. Chem.	1999	42	3126		Binding	Displacement of [3H]17-beta-estradiol from human estrogen receptor alpha	Human	logRBA	1.148		alpha		
10540-29-1	339	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Endo Y, Yoshimi T, Ohta K, Suzuki T, Ohta S.	J. Med. Chem.	2005	48	3941		Binding	Relative binding affinity (RBA) for human recombinant estrogen receptor alpha compared to [3H]-Estradiol at 4 nM	Human	logRBA	0.322		alpha		
10540-29-1	340	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schmid CR, Glasebrook AL, Misner JW, Stephenson GA.	Bioorg. Med. Chem. Lett.	1999	9	1137		Binding	Displacement of [3H]17-beta-estradiol from estrogen receptor of MCF-7 cell lysate as relative binding affinity	Human	logRBA	0		alpha		
10540-29-1	341	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative affinity for estrogen receptor of Human Breast cancer or normal uterine cytosol (3.3%ethanol) compared to estradiol	Human	logRBA	-0.036		alpha		
10540-29-1	342	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative Binding Affinity for estrogen receptor in Human Breast cancer or normal uterine cytosol in 3.3%ethanol compared to estradiol	Human	logRBA	-0.036		alpha		
10540-29-1	343	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hossain MB, van der Helm D, Schmitz FJ, Pordesimo EO, Magarian RA, Meyer KL, Overacre LB, Day BW.	J. Med. Chem.	1994	37	1670		Binding	Percent relative binding affinity (RBA) for estrogen receptor compared to estradiol	Human	logRBA	-0.046		alpha		
10540-29-1	344	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Rivera-Guevara C, PÃ©rez-Alvarez V, GarcÃ­a-Becerra R, Ordaz-Rosado D, Morales-RÃ­os MS, HernÃ¡ndez-Gallegos E, Cooney AJ, Bravo-GÃ³mez ME, Larrea F, Camacho J.	Bioorg. Med. Chem.	2010	18	5593		Binding	Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells after 18 hrs by liquid scintillation counting	Human	logRBA	-0.29		alpha		
10540-29-1	345	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Rivera-Guevara C, PÃ©rez-Alvarez V, GarcÃ­a-Becerra R, Ordaz-Rosado D, Morales-RÃ­os MS, HernÃ¡ndez-Gallegos E, Cooney AJ, Bravo-GÃ³mez ME, Larrea F, Camacho J.	Bioorg. Med. Chem.	2010	18	5593		Binding	Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells after 18 hrs by liquid scintillation counting relative to estradiol	Human	logRBA	-0.292		alpha		
10540-29-1	346	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Burke PJ, Koch TH.	J. Med. Chem.	2004	47	1193		Binding	Inhibition of [3H]E2 binding to estrogen receptor alpha in MCF-7 cell lysate	Human	logRBA	-1.125		alpha		
10540-29-1	347	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	1.67		alpha		
10540-29-1	348	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Shankar R, Chakravarti B, Singh US, Ansari MI, Deshpande S, Dwivedi SK, Bid HK, Konwar R, Kharkwal G, Chandra V, Dwivedi A, Hajela K.	Bioorg. Med. Chem.	2009	17	3847		Binding	Displacement of [3H]estradiol form ERalpha in rat uterine cytosol after 22 hrs by charcol adsorption method relative to 17-beta-estradiol	Rat	logRBA	0.342		alpha		
10540-29-1	349	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Knebel N, von Angerer E.	J. Med. Chem.	1988	31	1675		Binding	Relative binding affinity for the calf uterine estrogen receptor.	Cattle	logRBA	0.301		alpha		
10540-29-1	350	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Zablocki JA, Katzenellenbogen JA, Carlson KE, Norman MJ, Katzenellenbogen BS.	J. Med. Chem.	1987	30	829		Binding	Relative binding affinity (RBA) for Estrogen receptor compared to [3H]-estradiol	Sheep	logRBA	0.176		alpha		
10540-29-1	351	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Binding	Relative binding affinity to the estrogen receptor in lamb uterus cytosol	Sheep	logRBA	0.041		alpha		
10540-29-1	352	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	1.041		alpha	Full-length	
10540-29-1	353	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	0.845		alpha	Full-length	
10540-29-1	354	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	0.639		alpha	Full-length	
10540-29-1	355	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	0.602		alpha	Full-length	
10540-29-1	356	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	0.481		alpha	Full-length	
10540-29-1	357	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	0.002		alpha	Full-length	
10540-29-1	358	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	0.365		alpha	Full-length	
10540-29-1	359	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	1		alpha	Full-length	
10540-29-1	360	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	0.388		alpha	Full-length	
10540-29-1	361	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Binding	Displacement of fluorescein labeled estradiol from human recombinant ERbeta expressed in baculovirus infected insect cells by fluorescence polarization assay	Human	IC50	170	nM	beta		
10540-29-1	362	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Shani J, Gazit A, Livshitz T, Biran S.	J. Med. Chem.	1985	28	1504		Binding	Displacement of [3H]E2 specific binding to estrogen receptor	Rat	IC50	20	nM	beta		
10540-29-1	363	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hardcastle IR, Rowlands MG, Houghton J, Parr IB, Potter GA, Jarman M, Edwards KJ, Laughton CA, Trent JO, Neidle S.	J. Med. Chem.	1995	38	241		Binding	Receptor binding affinity(RBA) for rat uterine cytosolic estrogen receptor relative to estradiol	Rat	logRBA	0.602		beta		
10540-29-1	364	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Robertson DW, Katzenellenbogen JA, Hayes JR, Katzenellenbogen BS.	J. Med. Chem.	1982	25	167		Binding	Displacement of [3H]estradiol from estrogen receptor in rat uterine cytosol	Rat	logRBA	0.322		beta		
10540-29-1	365	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Sharma AP, Saeed A, Durani S, Kapil RS.	J. Med. Chem.	1990	33	3222		Binding	Relative binding affinity against estrogen receptor(ER)	Rat	logRBA	0.255		beta		
10540-29-1	366	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Kuroda R, Leclercq G, Stoessel S.	J. Med. Chem.	1986	29	2053		Binding	Relative binding affinity against estrogen receptor in cytosol assay	Rat	logRBA	0		beta		
10540-29-1	367	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Day BW, Magarian RA, Jain PT, Pento JT, Mousissian GK, Meyer KL.	J. Med. Chem.	1991	34	842		Binding	Relative binding affinity evaluated from the ability to displace [3H]estradiol from estrogen receptor in rat uterine cytosol preparation.	Rat	logRBA	-0.046		beta		
10540-29-1	368	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Kuroda R, Leclercq G, Stoessel S.	J. Med. Chem.	1986	29	2053		Binding	Relative binding affinity against estrogen receptor in whole cell assay	Rat	logRBA	-1.222		beta		
10540-29-1	369	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schneider MR, Ball H, Schiller CD.	J. Med. Chem.	1986	29	1355		Binding	Relative binding affinity against Estrogen receptor in immature mouse.	Mouse	logRBA	0.255		beta		
10540-29-1	370	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Binding	Relative binding affinity against estrogen receptor in calf uterus cytosol using [3H]E2 as radioligand, incubated at 2 hours at 0 degree Centigrade.	Cattle	logRBA	1.114		beta		
10540-29-1	371	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Knebel NG, von Angerer E.	J. Med. Chem.	1991	34	2145		Binding	Binding affinity towards calf uterine estrogen receptor using [3H]17-beta-estradiol as radioligand	Cattle	logRBA	0.255		beta		
10540-29-1	372	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2002	45	5358		Binding	Relative binding affinity for estrogen receptor of calf uterine cytosol with [3H]E2	Cattle	logRBA	0.255		beta		
10540-29-1	373	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2003	46	1484		Binding	Displacement of [3H]E2 from calf uterine estrogen receptor	Cattle	logRBA	0.255		beta		
10540-29-1	374	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Binding	Relative binding affinity against estrogen receptor in calf uterus cytosol using [3H]E2 as radioligand, incubated at 5 hours at 25 degree Centigrade.	Cattle	logRBA	0.041		beta		
10540-29-1	375	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	DorÃ© JC, Gilbert J, Bignon E, Crastes de Paulet A, Ojasoo T, Pons M, Raynaud JP, Miquel JF.	J. Med. Chem.	1992	35	573		Binding	Relative binding affinity was measured on calf uterus estrogen receptor after 5 hr at 25C.	Cattle	logRBA	0.041		beta		
10540-29-1	376	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Leclercq G.	J. Med. Chem.	1987	30	1761		Binding	Relative binding affinity for estrogen receptor of calf uterine cytosol	Cattle	logRBA	0		beta		
10540-29-1	377	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Leclercq G, Legros N, Goodman J, Blackburn GM, Jarman M, Foster AB.	J. Med. Chem.	1989	32	2527		Binding	Relative binding affinity against estrogen receptors in calf uterine cytosol.	Cattle	logRBA	0		beta		
10540-29-1	378	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	0.349		beta	Full-length	
10540-29-1	379	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	0.057		beta	Full-length	
10540-29-1	380	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERb binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	-1.77		beta	Full-length	
10540-29-1	381	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	0.778		beta	Full-length	
10540-29-1	382	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	0.778		beta	Full-length	
10540-29-1	383	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	0.477		beta	Full-length	
10540-29-1	384	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	-0.321		beta	Full-length	
10540-29-1	385	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	-0.58		beta	Full-length	
10540-29-1	386	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2003	46	1484		Reporter Gene	Inhibition of estradiol induced estrogen receptor transcriptional activation in MCF-7-2a cells	Human	IC50	500	nM			
10540-29-1	387	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Reporter Gene	Anti-estrogenicity for 50% inhibition of the MVLN cell luciferase activity due to 0.1 nM E2 (estradiol)	Human	IC50	300	nM			
10540-29-1	388	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Allan M, Manku S, Therrien E, Nguyen N, Styhler S, Robert MF, Goulet AC, Petschner AJ, Rahil G, Robert Macleod A, DÃ©ziel R, Besterman JM, Nguyen H, Wahhab A.	Bioorg. Med. Chem. Lett.	2009	19	1218		Reporter Gene	Antiestrogenic activity in human T47D cells expressing estrogen receptor assessed as estrogen-dependent transcription by luciferase reporter gene assay	Human	IC50	100	nM			
10540-29-1	389	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	1.663				
10540-29-1	390	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERa	Human	logRA	0.778				
10540-29-1	391	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	-2.301				
10540-29-1	392	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2003	46	1484		Reporter Gene	Agonistic effect on estrogen receptor mediated transcriptional activation in MCF-7-2a cells at 1 uM compared to 10e-8 M estradiol	Human	logRA	-10000				
10540-29-1	393	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERb	Rat	logRA	0.301				
10540-29-1	394	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schneider MR, Ball H, Schiller CD.	J. Med. Chem.	1986	29	1355		Reporter Gene	In vitro estrogenic effect in immature mice at 10 ug	Mouse	INH	100	%			
10540-29-1	395	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schneider MR, Ball H, Schiller CD.	J. Med. Chem.	1986	29	1355		Reporter Gene	In vitro estrogenic effect in immature mice at 100 ug	Mouse	INH	79	%			
10540-29-1	396	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schneider MR, Ball H, Schiller CD.	J. Med. Chem.	1986	29	1355		Reporter Gene	In vitro estrogenic effect in immature mice at 1 ug	Mouse	INH	43	%			
10540-29-1	397	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schneider MR, Ball H, Schiller CD.	J. Med. Chem.	1986	29	1355		Reporter Gene	Antiestrogenic effect in immature mouse at a dose of 25 ug.	Mouse	INH	11	%			
10540-29-1	398	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schneider MR, Ball H, Schiller CD.	J. Med. Chem.	1986	29	1355		Reporter Gene	Antiestrogenic effect in immature mouse at a dose of 1 ug.	Mouse	INH	0	%			
10540-29-1	399	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Reporter Gene	Antagonist activity at ERalpha expressed in yeast assessed as inhibition of E2-induced alpha-galactosidase activity		IC50	2540	nM	alpha		
10540-29-1	400	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Reporter Gene	Inhibitory concentration against estrogen receptor alpha using estrogen response element (ERE) assay.		IC50	622	nM	alpha		
10540-29-1	401	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Reporter Gene	Inhibition of 17-beta-estradiol mediated luciferase transcription in HeLa cells expressing human estrogen receptor alpha; ERE assay	Human	IC50	622	nM	alpha		
10540-29-1	402	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	-5.523		alpha	LBD	
10540-29-1	403	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Reporter Gene	Inhibitory concentration against estrogen receptor 2 using estrogen response element (ERE) assay.		IC50	1000	nM	beta		
10540-29-1	404	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Reporter Gene	Inhibition of 17-beta-estradiol mediated luciferase transcription in HeLa cells expressing human estrogen receptor beta; ERE assay	Human	IC50	1000	nM	beta		
10540-29-1	405	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Cell Proliferation	Antiproliferative activity against hormone independent human MDA-MB-231 cells upto 100 nM after 72 hrs by MTT assay	Human	IC50	-10000				
10540-29-1	406	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z.	J. Med. Chem.	2009	52	7544		Cell Proliferation	Agonist activity at estrogen receptor in human MCF7 cells assessed as 17-beta-estradiol-induced cell proliferation at 10 uM after 24 hrs by [14C]thymidine incorporation assay	Human	IC50	-10000				
10540-29-1	407	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Yadav Y, Maclean ED, Bhattacharyya A, Parmar VS, Balzarini J, Barden CJ, Too CK, Jha A.	Eur. J. Med. Chem.	2011	46	3858		Cell Proliferation	Cytotoxicity activity against human MCF7 cells by MTS assay	Human	IC50	31000	nM			
10540-29-1	408	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		Bioorg. Med. Chem. Lett.	1995	5	2217		Cell Proliferation	In vitro inhibition of estrogen receptor negative MDA-MD-231 human mammary carcinoma cell proliferation	Human	IC50	28000	nM			
10540-29-1	409	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kumar A, Tripathi VD, Kumar P, Gupta LP, Akanksha, Trivedi R, Bid H, Nayak VL, Siddiqui JA, Chakravarti B, Saxena R, Dwivedi A, Siddiquee MI, Siddiqui U, Konwar R, Chattopadhyay N.	Bioorg. Med. Chem.	2011	19	5409		Cell Proliferation	Antiproliferative activity against human Ishikawa cells expressing estrogen receptor after 48 hrs by MTT assay	Human	IC50	22500	nM			
10540-29-1	410	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Shankar R, Chakravarti B, Singh US, Ansari MI, Deshpande S, Dwivedi SK, Bid HK, Konwar R, Kharkwal G, Chandra V, Dwivedi A, Hajela K.	Bioorg. Med. Chem.	2009	17	3847		Cell Proliferation	Antiproliferative activity against human estrogen receptor deficient MDA-MB-231 cells after 48 hrs by MTT assay	Human	IC50	20000	nM			
10540-29-1	411	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Cell Proliferation	Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation	Human	IC50	19000	nM			
10540-29-1	412	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kumar A, Tripathi VD, Kumar P, Gupta LP, Akanksha, Trivedi R, Bid H, Nayak VL, Siddiqui JA, Chakravarti B, Saxena R, Dwivedi A, Siddiquee MI, Siddiqui U, Konwar R, Chattopadhyay N.	Bioorg. Med. Chem.	2011	19	5409		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MDA-MB-231 cells expressing estrogen receptor after 48 hrs by MTT assay	Human	IC50	18900	nM			
10540-29-1	413	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		Bioorg. Med. Chem. Lett.	1995	5	2217		Cell Proliferation	In vitro inhibition of estrogen receptor positive MCF-7 human mammary carcinoma cell proliferation	Human	IC50	17000	nM			
10540-29-1	414	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hardcastle IR, Rowlands MG, Houghton J, Parr IB, Potter GA, Jarman M, Edwards KJ, Laughton CA, Trent JO, Neidle S.	J. Med. Chem.	1995	38	241		Cell Proliferation	In vitro cytotoxicity against hormone-responsive MCF-7 cell line.	Human	IC50	14000	nM			
10540-29-1	415	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Cell Proliferation	Cytotoxicity against MCF-7 cells in presence of 1 uM E2 (estradiol)	Human	IC50	13000	nM			
10540-29-1	416	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kumar A, Tripathi VD, Kumar P, Gupta LP, Akanksha, Trivedi R, Bid H, Nayak VL, Siddiqui JA, Chakravarti B, Saxena R, Dwivedi A, Siddiquee MI, Siddiqui U, Konwar R, Chattopadhyay N.	Bioorg. Med. Chem.	2011	19	5409		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by MTT assay	Human	IC50	12480	nM			
10540-29-1	417	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Sashidhara KV, Rosaiah JN, Kumar M, Gara RK, Nayak LV, Srivastava K, Bid HK, Konwar R.	Bioorg. Med. Chem. Lett.	2010	20	7127		Cell Proliferation	Anticancer activity against human MCF7 cells expressing estrogen receptor by MTT assay	Human	IC50	11800	nM			
10540-29-1	418	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lloyd DG, Hughes RB, Zisterer DM, Williams DC, Fattorusso C, Catalanotti B, Campiani G, Meegan MJ.	J. Med. Chem.	2004	47	5612		Cell Proliferation	Inhibition of estrogen receptor positive human breast carcinoma (MCF-7) cell proliferation	Human	IC50	11300	nM			
10540-29-1	419	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Meegan MJ, Hughes RB, Lloyd DG, Williams DC, Zisterer DM.	J. Med. Chem.	2001	44	1072		Cell Proliferation	Antiproliferative activity against Human MCF-7 Breast cancer cell line in vitro.	Human	IC50	11280	nM			
10540-29-1	420	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Shankar R, Chakravarti B, Singh US, Ansari MI, Deshpande S, Dwivedi SK, Bid HK, Konwar R, Kharkwal G, Chandra V, Dwivedi A, Hajela K.	Bioorg. Med. Chem.	2009	17	3847		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by MTT assay	Human	IC50	10000	nM			
10540-29-1	421	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Cell Proliferation	Cytotoxicity against MCF-7 cells in the absence of 1 uM E2 (estradiol)	Human	IC50	9800	nM			
10540-29-1	422	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Cell Proliferation	Cytostaticity against MCF-7 cells in the presence of 1 uMolar E2 (estradiol)	Human	IC50	8000	nM			
10540-29-1	423	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Teo CC, Kon OL, Sim KY, Ng SC.	J. Med. Chem.	1992	35	1330		Cell Proliferation	Inhibition of [3H]thymidine incorporation into MCF-7 cells	Human	IC50	7200	nM			
10540-29-1	424	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Cell Proliferation	Antiproliferative activity against estrogen receptor dependent human MCF7 cells after 72 hrs by MTT assay	Human	IC50	4120	nM			
10540-29-1	425	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Burke PJ, Koch TH.	J. Med. Chem.	2004	47	1193		Cell Proliferation	Inhibition of MCF-7/Adr breast cancer cell proliferation	Human	IC50	2000	nM			
10540-29-1	426	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human NCI-ADR-RES cells incubated with 100 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	1148.2	nM			
10540-29-1	427	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Allan M, Manku S, Therrien E, Nguyen N, Styhler S, Robert MF, Goulet AC, Petschner AJ, Rahil G, Robert Macleod A, DÃ©ziel R, Besterman JM, Nguyen H, Wahhab A.	Bioorg. Med. Chem. Lett.	2009	19	1218		Cell Proliferation	Growth inhibition of human estrogen-dependent T47D cells after 72 hrs	Human	IC50	1000	nM			
10540-29-1	428	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Nagaiah K, Venkatesham A, Srinivasa Rao R, Saddanapu V, Yadav JS, Basha SJ, Sarma AV, Sridhar B, Addlagatta A.	Bioorg. Med. Chem. Lett.	2010	20	3259		Cell Proliferation	Antiproliferative activity against human MCF7 cells by MTT assay	Human	IC50	1000	nM			
10540-29-1	429	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human NCI-ADR-RES cells incubated with 0.06 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	955	nM			
10540-29-1	430	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schmid CR, Glasebrook AL, Misner JW, Stephenson GA.	Bioorg. Med. Chem. Lett.	1999	9	1137		Cell Proliferation	Inhibition of 17-beta-estradiol (10e-11 M) mediated MCF-7 cell proliferation	Human	IC50	904	nM			
10540-29-1	431	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MCF12A cells incubated with 0.06 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	691.8	nM			
10540-29-1	432	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Nagaiah K, Venkatesham A, Srinivasa Rao R, Saddanapu V, Yadav JS, Basha SJ, Sarma AV, Sridhar B, Addlagatta A.	Bioorg. Med. Chem. Lett.	2010	20	3259		Cell Proliferation	Antiproliferative activity against human MDA-MB-231 cells by MTT assay	Human	IC50	660	nM			
10540-29-1	433	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Cell Proliferation	Inhibitory concentration against MCF-7 breast tumor cells using MCF-7 assay.	Human	IC50	580	nM			
10540-29-1	434	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Cell Proliferation	Inhibition of estrogen-mediated human breast adenocarcinoma (MCF-7) cell proliferation	Human	IC50	580	nM			
10540-29-1	435	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MCF12A cells incubated with 0.003 nM of estradiol and 0.01 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of 5% fetal bovine serum	Human	GI50	575.4	nM			
10540-29-1	436	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MCF12A cells incubated with 100 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	575.4	nM			
10540-29-1	437	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human NCI-ADR-RES cells incubated with 0.003 nM of estradiol and 0.01 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of 5% fetal bovine serum	Human	GI50	575.4	nM			
10540-29-1	438	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor incubated with 100 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	562.3	nM			
10540-29-1	439	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		Bioorg. Med. Chem. Lett.	1997	7	887		Cell Proliferation	Antagonist effect in breast tissue was assayed by inhibition of estrogen stimulated MCF-7 cell proliferation	Human	IC50	530	nM			
10540-29-1	440	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor incubated with 0.06 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	295.1	nM			
10540-29-1	441	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor incubated with 0.003 nM of estradiol and 0.01 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of 5% fetal bovine serum	Human	GI50	229.1	nM			
10540-29-1	442	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Goldbrunner M, Loidl G, Polossek T, Mannschreck A, von Angerer E.	J. Med. Chem.	1997	40	3524		Cell Proliferation	Inhibition of estrogen receptor positive MCF-7 human breast cancer cell proliferation	Human	IC50	150	nM			
10540-29-1	443	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Cell Proliferation	Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol	Human	IC50	140	nM			
10540-29-1	444	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Leclercq G, Legros N, Goodman J, Blackburn GM, Jarman M, Foster AB.	J. Med. Chem.	1989	32	2527		Cell Proliferation	Growth inhibitory activity against MCF-7 human breast tumor cell line at a concentration of 10e-8 M in vitro.	Human	INH	119	%			
10540-29-1	445	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Leclercq G, Legros N, Goodman J, Blackburn GM, Jarman M, Foster AB.	J. Med. Chem.	1989	32	2527		Cell Proliferation	Growth inhibitory activity against MCF-7 human breast tumor cell line at a concentration of 10e-7 M in vitro.	Human	INH	100	%			
10540-29-1	446	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kraft KS, Ruenitz PC, Bartlett MG.	J. Med. Chem.	1999	42	3126		Cell Proliferation	Inhibition of MCF-7 cell proliferation at 10 nM	Human	INH	97	%			
10540-29-1	447	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Shen J, Tan C, Zhang Y, Li X, Li W, Huang J, Shen X, Tang Y.	J. Med. Chem.	2010	53	5361		Cell Proliferation	Antiproliferative activity against human MCF7 cells assessed as viable cells at 100 uM after 24 hrs by MTT assay	Human	INH	93.33	%			
10540-29-1	448	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Cell Proliferation	Percent of inhibitory activity versus 0.1 nm [3H]estradiol against proliferation of MCF-7 cells.	Human	INH	90	%			
10540-29-1	449	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hartmann RW, Buchborn H, Kranzfelder G, Schnenberger H, Bogden A.	J. Med. Chem.	1981	24	1192		Cell Proliferation	Inhibition of estrogen receptor positive MCF-7 cell proliferation as percent treated/control cell number after 10 days at 10e-8 M	Human	INH	87	%			
10540-29-1	450	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Polossek T, Ambros R, von Angerer S, Brandl G, Mannschreck A, von Angerer E.	J. Med. Chem.	1992	35	3537		Cell Proliferation	Inhibition of hormone-sensitive MCF-7 mammary tumor cell proliferation at 1*10e-7 M	Human	INH	85	%			
10540-29-1	451	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Burke PJ, Koch TH.	J. Med. Chem.	2004	47	1193		Cell Proliferation	Inhibition of estrogen receptor negative MDA-MB-231 breast cancer cell proliferation	Human	IC50	80	nM			
10540-29-1	452	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hartmann RW, Buchborn H, Kranzfelder G, Schnenberger H, Bogden A.	J. Med. Chem.	1981	24	1192		Cell Proliferation	Inhibition of estrogen receptor positive MCF-7 cell proliferation as percent treated/control cell number after 10 days at 10e-7 M	Human	INH	79	%			
10540-29-1	453	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hartmann RW, Buchborn H, Kranzfelder G, Schnenberger H, Bogden A.	J. Med. Chem.	1981	24	1192		Cell Proliferation	Inhibition of estrogen receptor positive MCF-7 cell proliferation as percent treated/control cell number after 10 days at 10e-6 M	Human	INH	75	%			
10540-29-1	454	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kraft KS, Ruenitz PC, Bartlett MG.	J. Med. Chem.	1999	42	3126		Cell Proliferation	Inhibition of MCF-7 cell proliferation at 100 nM	Human	INH	72	%			
10540-29-1	455	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Day BW, Magarian RA, Jain PT, Pento JT, Mousissian GK, Meyer KL.	J. Med. Chem.	1991	34	842		Cell Proliferation	Antiproliferative activity against estrogen receptor positive MCF-7 human breast cancer cell line at a dose of 10e-5 M. (p<0.05)	Human	INH	71.9	%			
10540-29-1	456	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McCague R, Leclercq G, Legros N, Goodman J, Blackburn GM, Jarman M, Foster AB.	J. Med. Chem.	1989	32	2527		Cell Proliferation	Growth inhibitory activity against MCF-7 human breast tumor cell line at a concentration of 10e-6 M in vitro.	Human	INH	70	%			
10540-29-1	457	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Burke PJ, Koch TH.	J. Med. Chem.	2004	47	1193		Cell Proliferation	Inhibition of estrogen receptor positive MCF-7 breast cancer cell proliferation	Human	IC50	70	nM			
10540-29-1	458	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Cell Proliferation	Percent antagonist activity against human breast adenocarcinoma (MCF-7) cell proliferation	Human	Antagonism	68	%			
10540-29-1	459	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Polossek T, Ambros R, von Angerer S, Brandl G, Mannschreck A, von Angerer E.	J. Med. Chem.	1992	35	3537		Cell Proliferation	Inhibition of hormone-sensitive MCF-7 mammary tumor cell proliferation at 1*10e-6 M	Human	INH	57	%			
10540-29-1	460	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hossain MB, van der Helm D, Schmitz FJ, Pordesimo EO, Magarian RA, Meyer KL, Overacre LB, Day BW.	J. Med. Chem.	1994	37	1670		Cell Proliferation	Percent inhibition of estrogen receptor positive MCF-7 human breast cancer cell proliferation at 10e-7 M	Human	INH	52	%			
10540-29-1	461	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Day BW, Magarian RA, Jain PT, Pento JT, Mousissian GK, Meyer KL.	J. Med. Chem.	1991	34	842		Cell Proliferation	Antiproliferative activity against estrogen receptor positive MCF-7 human breast cancer cell line at a dose of 10e-7 M. (p<0.05)	Human	INH	51.8	%			
10540-29-1	462	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Ambros R, Schneider MR, von Angerer S.	J. Med. Chem.	1990	33	153		Cell Proliferation	Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-6M	Human	INH	51	%			
10540-29-1	463	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Polossek T, Ambros R, von Angerer S, Brandl G, Mannschreck A, von Angerer E.	J. Med. Chem.	1992	35	3537		Cell Proliferation	Inhibition of hormone-sensitive MCF-7 mammary tumor cell proliferation at 5*10e-6 M	Human	INH	43	%			
10540-29-1	464	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kraft KS, Ruenitz PC, Bartlett MG.	J. Med. Chem.	1999	42	3126		Cell Proliferation	Inhibition of estrogen-induced MCF-7 cell proliferation at 10000 nM	Human	INH	31	%			
10540-29-1	465	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kraft KS, Ruenitz PC, Bartlett MG.	J. Med. Chem.	1999	42	3126		Cell Proliferation	Inhibition of MCF-7 cell proliferation at 10000 nM	Human	INH	24	%			
10540-29-1	466	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Day BW, Magarian RA, Jain PT, Pento JT, Mousissian GK, Meyer KL.	J. Med. Chem.	1991	34	842		Cell Proliferation	Antiproliferative activity against estrogen receptor positive MCF-7 human breast cancer cell line at 10e-9 M. (p<0.05)	Human	INH	20.5	%			
10540-29-1	467	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Polossek T, Ambros R, von Angerer S, Brandl G, Mannschreck A, von Angerer E.	J. Med. Chem.	1992	35	3537		Cell Proliferation	Inhibition of hormone-sensitive MCF-7 mammary tumor cell proliferation at 1*10e-5 M	Human	INH	18	%			
10540-29-1	468	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Ambros R, Schneider MR, von Angerer S.	J. Med. Chem.	1990	33	153		Cell Proliferation	Effect on hormone-dependent MCF-7 human breast cancer cell proliferation at 1x10E-5 M	Human	INH	17	%			
10540-29-1	469	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Percentage cell number change as treated/control in hormone sensitive MCF-7 cell proliferation assay at 10e-6 M or 10e-5 M	Human	INH	12	%			
10540-29-1	470	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Percentage [3H]thymidine incorporation treated/control in hormone sensitive MCF-7 cell proliferation assay at 10e-5 M or 10e-6 M	Human	INH	6	%			
10540-29-1	471	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Dong Y, Shi Q, Liu YN, Wang X, Bastow KF, Lee KH.	J. Med. Chem.	2009	52	3586		Cell Proliferation	Cytotoxicity against human MCF7 cells expressing estrogen receptor after 72 hrs by SRB assay	Human	ED50	5	ug/ml			
10540-29-1	472	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Dong Y, Shi Q, Liu YN, Wang X, Bastow KF, Lee KH.	J. Med. Chem.	2009	52	3586		Cell Proliferation	Cytotoxicity against estrogen receptor deficient human SKBR3 cells overexpressing human epidermal growth factor receptor 2 after 72 hrs by SRB assay	Human	ED50	5	ug/ml			
10540-29-1	473	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Percentage cell number change as treated/control in hormone sensitive MCF-7 cell proliferation assay at 10e-6 M or 10e-5 M	Human	INH	2	%			
10540-29-1	474	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Inhibition of [3H]thymidine incorporation into hormone sensitive MCF-7 human breast cancer cells at 10e-6 M	Human	INH	0.48	%			
10540-29-1	475	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Inhibition of [3H]thymidine incorporation into hormone sensitive MCF-7 human breast cancer cells at 10e-5 M	Human	INH	0.2	%			
10540-29-1	476	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Inhibition of [3H]thymidine incorporation into hormone sensitive MCF-7 human breast cancer cells at 10e-6 M	Human	INH	0.185	%			
10540-29-1	477	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Inhibition of [3H]thymidine incorporation into hormone sensitive MCF-7 human breast cancer cells at 10e-5 M	Human	INH	0.008	%			
10540-29-1	478	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	von Angerer E, Prekajac J.	J. Med. Chem.	1986	29	380		Cell Proliferation	Percentage [3H]thymidine incorporation treated/control in hormone sensitive MCF-7 cell proliferation assay at 10e-5 M or 10e-6 M	Human	INH	0	%			
10540-29-1	479	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Cell Proliferation	Inhibition of estrogen receptor negative MDA-MB-453 breast cancer cell proliferation with 10e-4 M estradiol	Human	IC50	5000	nM			
10540-29-1	480	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Cell Proliferation	Percent agonistic activity in MCF-7 breast tumor cells using MCF-7 assay	Human	logRE	1.623				
10540-29-1	481	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Cell Proliferation	Percent agonist activity against human breast adenocarcinoma (MCF-7) cell proliferation	Human	logRE	1.623				
10540-29-1	482	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Cell Proliferation	Percent of effective dose for [3H]estradiol against proliferation of MCF-7 cells.	Human	logRE	1.322				
10540-29-1	483	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	DorÃ© JC, Gilbert J, Bignon E, Crastes de Paulet A, Ojasoo T, Pons M, Raynaud JP, Miquel JF.	J. Med. Chem.	1992	35	573		Cell Proliferation	Agonistic activity in MCF-7 cell proliferation.	Human	logRE	1.322				
10540-29-1	484	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	-1.3				
10540-29-1	485	2	tamoxifen	C26H29NO	371.51	4.97		CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	1				Sc
446-72-0	486	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	0.359				
446-72-0	487	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	-0.265				
446-72-0	488	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr.	Chem. Res. Toxicol. 	1996	9	1240		Binding	Competitive estrogen receptor binding assays using mouse uterine cytosol	Mouse	logRBA	-0.176				
446-72-0	489	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	0.114			LBD	
446-72-0	490	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	-0.108			LBD	
446-72-0	491	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	-0.357			LBD	
446-72-0	492	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Binding	Binding affinity towards estrogen receptor alpha by [3H]17-beta-estradiol displacement.		logRBA	-0.744		alpha		
446-72-0	493	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Binding	Binding affinity for estrogen receptor, by competition with [3H]estradiol		logRBA	-0.792		alpha		
446-72-0	494	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor Alpha	Human	IC50	4660	nM	alpha		
446-72-0	495	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha	Human	IC50	1300	nM	alpha		
446-72-0	496	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Chen W, Lin Z, Ning M, Yang C, Yan X, Xie Y, Shen X, Wang MW.	Bioorg. Med. Chem.	2007	15	5828		Binding	Displacement of [3H]17beta-estradiol from recombinant human ERalpha	Human	IC50	580	nM	alpha		
446-72-0	497	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha	Human	Ki	370	nM	alpha		
446-72-0	498	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	CalderÃ³n AI, Terreaux C, Schenk K, Pattison P, Burdette JE, Pezzuto JM, Gupta MP, Hostettmann K.	J. Nat. Prod.	2002	65	1749		Binding	Displacement of [3H]estradiol from human recombinant ERalpha	Human	IC50	300	nM	alpha		
446-72-0	499	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Vu AT, Campbell AN, Harris HA, Unwalla RJ, Manas ES, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	4053		Binding	Inhibition of human ERalpha	Human	logRBA	1.556		alpha		
446-72-0	500	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Chesworth R, Wessel MD, Heyden L, Mangano FM, Zawistoski M, Gegnas L, Galluzzo D, Lefker B, Cameron KO, Tickner J, Lu B, Castleberry TA, Petersen DN, Brault A, Perry P, Ng O, Owen TA, Pan L, Ke HZ, Brown TA, Thompson DD, DaSilva-Jardine P.	Bioorg. Med. Chem. Lett.	2005	15	5562		Binding	Displacement of [3H]17beta-estradiol from recombinant human ERalpha expressed in 293T cells	Human	logRBA	0.407		alpha		
446-72-0	501	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor alpha in competitive binding assay	Human	logRBA	0.15		alpha		
446-72-0	502	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Yang C, Edsall R Jr, Harris HA, Zhang X, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2004	12	2553		Binding	solid phase radioligand binding assay of ERa	Human	logRBA	-0.091		alpha		
446-72-0	503	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Miller CP, Collini MD, Harris HA.	Bioorg. Med. Chem. Lett.	2003	13	2399		Binding	Binding affinity towards human estrogen receptor alpha(ERalpha)	Human	logRBA	-0.091		alpha		
446-72-0	504	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Collini MD, Kaufman DH, Manas ES, Harris HA, Henderson RA, Xu ZB, Unwalla RJ, Miller CP.	Bioorg. Med. Chem. Lett.	2004	14	4925		Binding	Binding affinity for human Estrogen receptor alpha	Human	logRBA	-0.091		alpha		
446-72-0	505	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2005	15	4520		Binding	Binding affinity for human Estrogen receptor alpha	Human	logRBA	-0.091		alpha		
446-72-0	506	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST.	Bioorg. Med. Chem. Lett.	2007	17	902		Binding	Inhibition of human ERalpha by radioligand binding assay	Human	logRBA	-0.091		alpha		
446-72-0	507	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Mewshaw RE, Edsall RJ Jr, Yang C, Manas ES, Xu ZB, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2005	48	3953		Binding	Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha expressed in Escherichia coli	Human	logRBA	-0.091		alpha		
446-72-0	508	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha.	Human	logRBA	-0.213		alpha		
446-72-0	509	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	GÃ¼ngr T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.	J. Med. Chem.	2006	49	2440		Binding	Displacement of [3H]estrone from ER alpha	Human	logRBA	-0.295		alpha		
446-72-0	510	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Zhao L, Jin C, Mao Z, Gopinathan MB, Rehder K, Brinton RD.	J. Med. Chem.	2007	50	4471		Binding	Binding affinity to human ERalpha	Human	logRBA	-0.66		alpha		
446-72-0	511	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Wright JS, Shadnia H, Anderson JM, Durst T, Asim M, El-Salfiti M, Choueiri C, Pratt MA, Ruddy SC, Lau R, Carlson KE, Katzenellenbogen JA, OBrien PJ, Wan L.	J. Med. Chem.	2011	54	433		Binding	Displacement of [3H]estradiol from human ERalpha after 18 to 24 hrs relative to estradiol	Human	logRBA	-1.721		alpha		
446-72-0	512	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	-0.92		alpha		
446-72-0	513	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	0.699		alpha	Full-length	
446-72-0	514	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	0.602		alpha	Full-length	
446-72-0	515	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Hu JY, Aizawa T.	Water Res.	2003	37	1213		Binding	human receptor binding competition assay of ER	Human	logRBA	0.402		alpha	Full-length	
446-72-0	516	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	0.249		alpha	Full-length	
446-72-0	517	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	0.204		alpha	Full-length	
446-72-0	518	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Binding	Relative binding affinity (RBA) at Human estrogen receptor alpha (radiometric binding assay with [3H]estradiol using full-length human ER alpha)	Human	logRBA	-0.155		alpha	Full-length	
446-72-0	519	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	-0.227		alpha	Full-length	
446-72-0	520	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	-0.337		alpha	Full-length	
446-72-0	521	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	-0.183		alpha	Full-length	
446-72-0	522	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	-0.286		alpha	Full-length	
446-72-0	523	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	-0.481		alpha	Full-length	
446-72-0	524	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Ullrich JW, Unwalla RJ, Singhaus RR Jr, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	118		Binding	Inhibition of human LBD of of ERalpha	Human	logRBA	1.57		alpha	LBD	
446-72-0	525	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2003	11	3457		Binding	solid phase radioligand binding assay of ERa	Human	logRBA	-0.091		alpha	LBD	
446-72-0	526	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay against human ER alpha expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand	Human	logRBA	-0.091		alpha	LBD	
446-72-0	527	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Roelens F, Heldring N, Dhooge W, Bengtsson M, Comhaire F, Gustafsson JA, Treuter E, De Keukeleire D.	J. Med. Chem.	2006	49	7357		Binding	Displacement of [3H]E2 from human recombinant ERalpha LBD by SPA	Human	logRBA	-0.98		alpha	LBD	
446-72-0	528	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Binding	Binding affinity towards estrogen receptor beta by [3H]17-beta-estradiol displacement.		logRBA	0.688		beta		
446-72-0	529	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor beta	Human	IC50	98.7	nM	beta		
446-72-0	530	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta	Human	IC50	83	nM	beta		
446-72-0	531	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta	Human	Ki	24	nM	beta		
446-72-0	532	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	CalderÃ³n AI, Terreaux C, Schenk K, Pattison P, Burdette JE, Pezzuto JM, Gupta MP, Hostettmann K.	J. Nat. Prod.	2002	65	1749		Binding	Displacement of [3H]estradiol from human recombinant ERbeta	Human	IC50	18	nM	beta		
446-72-0	533	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Chen W, Lin Z, Ning M, Yang C, Yan X, Xie Y, Shen X, Wang MW.	Bioorg. Med. Chem.	2007	15	5828		Binding	Displacement of [3H]17beta-estradiol from recombinant human ERbeta	Human	IC50	6.8	nM	beta		
446-72-0	534	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Chesworth R, Wessel MD, Heyden L, Mangano FM, Zawistoski M, Gegnas L, Galluzzo D, Lefker B, Cameron KO, Tickner J, Lu B, Castleberry TA, Petersen DN, Brault A, Perry P, Ng O, Owen TA, Pan L, Ke HZ, Brown TA, Thompson DD, DaSilva-Jardine P.	Bioorg. Med. Chem. Lett.	2005	15	5562		Binding	Displacement of [3H]17beta-estradiol from recombinant human ERbeta expressed in 293T cells	Human	logRBA	1.958		beta		
446-72-0	535	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Yang C, Edsall R Jr, Harris HA, Zhang X, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2004	12	2553		Binding	solid phase radioligand binding assay of ERb	Human	logRBA	1.57		beta		
446-72-0	536	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Mewshaw RE, Bowen SM, Harris HA, Xu ZB, Manas ES, Cohn ST.	Bioorg. Med. Chem. Lett.	2007	17	902		Binding	Inhibition of human ERbeta by radioligand binding assay	Human	logRBA	1.57		beta		
446-72-0	537	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Mewshaw RE, Edsall RJ Jr, Yang C, Manas ES, Xu ZB, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2005	48	3953		Binding	Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor beta expressed in Escherichia coli	Human	logRBA	1.57		beta		
446-72-0	538	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Miller CP, Collini MD, Harris HA.	Bioorg. Med. Chem. Lett.	2003	13	2399		Binding	Binding affinity towards human estrogen receptor beta (ERbeta)	Human	logRBA	1.556		beta		
446-72-0	539	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Collini MD, Kaufman DH, Manas ES, Harris HA, Henderson RA, Xu ZB, Unwalla RJ, Miller CP.	Bioorg. Med. Chem. Lett.	2004	14	4925		Binding	Binding affinity for human Estrogen receptor beta	Human	logRBA	1.556		beta		
446-72-0	540	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Vu AT, Cohn ST, Manas ES, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2005	15	4520		Binding	Binding affinity for human Estrogen receptor beta	Human	logRBA	1.556		beta		
446-72-0	541	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay	Human	logRBA	1.439		beta		
446-72-0	542	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	GÃ¼ngr T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.	J. Med. Chem.	2006	49	2440		Binding	Displacement of [3H]estrone from ER beta	Human	logRBA	1.256		beta		
446-72-0	543	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta.	Human	logRBA	1.079		beta		
446-72-0	544	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Wright JS, Shadnia H, Anderson JM, Durst T, Asim M, El-Salfiti M, Choueiri C, Pratt MA, Ruddy SC, Lau R, Carlson KE, Katzenellenbogen JA, OBrien PJ, Wan L.	J. Med. Chem.	2011	54	433		Binding	Displacement of [3H]estradiol from human ERbeta after 18 to 24 hrs relative to estradiol	Human	logRBA	0.87		beta		
446-72-0	545	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Vu AT, Campbell AN, Harris HA, Unwalla RJ, Manas ES, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	4053		Binding	Inhibition of human ERbeta	Human	logRBA	-0.091		beta		
446-72-0	546	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Zhao L, Jin C, Mao Z, Gopinathan MB, Rehder K, Brinton RD.	J. Med. Chem.	2007	50	4471		Binding	Binding affinity to human ERbeta	Human	logRBA	-1.439		beta		
446-72-0	547	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	1.571		beta	Full-length	
446-72-0	548	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	1.548		beta	Full-length	
446-72-0	549	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Binding	Relative binding affinity (RBA) at human estrogen receptor beta (radiometric binding assay with [3H]estradiol using full-length human ER Beta)	Human	logRBA	1.114		beta	Full-length	
446-72-0	550	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	1.94		beta	Full-length	
446-72-0	551	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	1.556		beta	Full-length	
446-72-0	552	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	1.556		beta	Full-length	
446-72-0	553	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	1.499		beta	Full-length	
446-72-0	554	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	1.739		beta	Full-length	
446-72-0	555	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE.	Bioorg. Med. Chem.	2003	11	3457		Binding	solid phase radioligand binding assay of ERb	Human	logRBA	1.57		beta	LBD	
446-72-0	556	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr, Harris HA.	J. Med. Chem.	2004	47	5021		Binding	Competitive radioligand binding assay against human ER beta expressed in Escherichia coli was determined using [3H]17-beta-estradiol as radio ligand	Human	logRBA	1.556		beta	LBD	
446-72-0	557	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Roelens F, Heldring N, Dhooge W, Bengtsson M, Comhaire F, Gustafsson JA, Treuter E, De Keukeleire D.	J. Med. Chem.	2006	49	7357		Binding	Displacement of [3H]E2 from human recombinant ERbeta LBD by SPA	Human	logRBA	0.748		beta	LBD	
446-72-0	558	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Ullrich JW, Unwalla RJ, Singhaus RR Jr, Harris HA, Mewshaw RE.	Bioorg. Med. Chem. Lett.	2007	17	118		Binding	Inhibition of human LBD of ERbeta	Human	logRBA	-0.091		beta	LBD	
446-72-0	559	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERa	Human	logRA	2.297				
446-72-0	560	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	1.785				
446-72-0	561	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	-1.31				
446-72-0	562	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERb	Rat	logRA	2.26				
446-72-0	563	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Reporter Gene	Ability to activate estrogen receptor 1-mediated transcription.		logRA	-1.296		alpha		
446-72-0	564	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Transcriptional potency (EC50) at Human estrogen receptor alpha	Human	logRA	-1.046		alpha		
446-72-0	565	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.	Human	logRA	-1.38		alpha		
446-72-0	566	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Relative estrogenic potency at Human estrogen receptor alpha (EC50 (Estradiol) / EC50 (ligand))	Human	logRA	-1.602		alpha		
446-72-0	567	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	-0.523		alpha	LBD	
446-72-0	568	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Reporter Gene	Ability to activate estrogen receptor 2-mediated transcription.		logRA	-0.475		beta		
446-72-0	569	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Collini MD, Kaufman DH, Manas ES, Harris HA, Henderson RA, Xu ZB, Unwalla RJ, Miller CP.	Bioorg. Med. Chem. Lett.	2004	14	4925		Reporter Gene	Percent effect on estrogen receptor beta mediated-IGFBP4 transcriptional regulation in SAOS-2 cells (human osteosarcoma cells) at 1 uM	Human	logRA	2.021		beta		
446-72-0	570	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta	Human	logRA	0.77		beta		
446-72-0	571	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.	Human	logRA	0.232		beta		
446-72-0	572	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Relative estrogenic potency at Human estrogen receptor Beta (EC50 (Estradiol) / EC50 (ligand))	Human	logRA	-0.097		beta		
446-72-0	573	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.	J. Med. Chem.	2001	44	4230		Reporter Gene	Transcriptional potency (EC50) at Human estrogen receptor Beta	Human	logRA	-0.187		beta		
446-72-0	574	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Cell Proliferation	Inhibition of 10e-4 uM estradiol induced estrogen receptor positive MCF-7 human breast cancer cell proliferation	Human	IC50	77000	nM			
446-72-0	575	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Ndejouong Ble S, Sattler I, Dahse HM, Kothe E, Hertweck C.	Bioorg. Med. Chem. Lett.	2009	19	6473		Cell Proliferation	Antiproliferative activity against estrogen receptor expressing human MDA-MB-436 cells	Human	GI50	17000	nM			
446-72-0	576	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M.	J. Med. Chem.	1996	39	3461		Cell Proliferation	Anti-proliferative activity against estrogen-responsive human breast cancer cell line MCF-7 in the presence of ER at a 10e-4 uM concentration of estradiol	Human	IC50	11000	nM			
446-72-0	577	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Ndejouong Ble S, Sattler I, Dahse HM, Kothe E, Hertweck C.	Bioorg. Med. Chem. Lett.	2009	19	6473		Cell Proliferation	Antiproliferative activity against estrogen receptor expressing human MCF7 cells	Human	GI50	10000	nM			
446-72-0	578	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor incubated with 0.003 nM of estradiol and 0.01 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of 5% fetal bovine serum	Human	GI50	6166	nM			
446-72-0	579	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor incubated with 100 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	5248.1	nM			
446-72-0	580	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against human MCF7 cells expressing estrogen receptor incubated with 0.06 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	4570.9	nM			
446-72-0	581	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MCF12A cells incubated with 0.003 nM of estradiol and 0.01 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of 5% fetal bovine serum	Human	GI50	3235.9	nM			
446-72-0	582	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human NCI-ADR-RES cells incubated with 0.003 nM of estradiol and 0.01 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of 5% fetal bovine serum	Human	GI50	3235.9	nM			
446-72-0	583	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MCF12A cells incubated with 100 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	3020	nM			
446-72-0	584	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human NCI-ADR-RES cells incubated with 100 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	2691.5	nM			
446-72-0	585	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human MCF12A cells incubated with 0.06 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	2187.8	nM			
446-72-0	586	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Khupse RS, Sarver JG, Trendel JA, Bearss NR, Reese MD, Wiese TE, Boue SM, Burow ME, Cleveland TE, Bhatnagar D, Erhardt PW.	J. Med. Chem.	2011	54	3506		Cell Proliferation	Antiproliferative activity against estrogen receptor-deficient human NCI-ADR-RES cells incubated with 0.06 nM of estradiol and 0.07 nM of testosterone after 48 hrs by sulforhodamine B assay in presence of fetal bovine serum and NuSerum	Human	GI50	1698.2	nM			
446-72-0	587	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Gakh AA, Anisimova NY, Kiselevsky MV, Sadovnikov SV, Stankov IN, Yudin MV, Rufanov KA, Krasavin MY, Sosnov AV.	Bioorg. Med. Chem. Lett.	2010	20	6149		Cell Proliferation	Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay	Human	IC50	1000	nM			
446-72-0	588	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Cell Proliferation	Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 10 uM	Human	INH	197.2	%			
446-72-0	589	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Cell Proliferation	Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 1 uM	Human	INH	171.5	%			
446-72-0	590	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	-1.85				
446-72-0	591	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	-2.4				
446-72-0	592	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	-2.7				Sc
446-72-0	593	3	genistein	C15H10O5	270.24	2.22		Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	-2.96				oral
84449-90-1	594	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Congreve M, Chessari G, Tisi D, Woodhead AJ.	J. Med. Chem.	2008	51	3661		Binding	Activity against estrogen receptor alpha		EC50	22	nM	alpha		
84449-90-1	595	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z.	J. Med. Chem.	2009	52	7544		Binding	Displacement of radiolabeled estrogen from estrogen receptor alpha by scintillation counting		IC50	1.8	nM	alpha		
84449-90-1	596	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Drewry DH, Jones SA, Stewart EL, Weaver SL, Wiethe RW.	Bioorg. Med. Chem. Lett.	2001	11	1939		Binding	Ability to displace [3H]17-beta-estradiol from Estrogen receptor alpha by scintillation proximity assay.		logRBA	3		alpha		
84449-90-1	597	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	McKie JA, Bhagwat SS, Brady H, Doubleday M, Gayo L, Hickman M, Jalluri RK, Khammungkhune S, Kois A, Mortensen D, Richard N, Sapienza J, Shevlin G, Stein B, Sutherland M.	Bioorg. Med. Chem. Lett.	2004	14	3407		Binding	Binding affinity against estrogen receptor alpha relative to E2		logRBA	1.544		alpha		
84449-90-1	598	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Grese TA, Cho S, Finley DR, Godfrey AG, Jones CD, Lugar CW 3rd, Martin MJ, Matsumoto K, Pennington LD, Winter MA, Adrian MD, Cole HW, Magee DE, Phillips DL, Rowley ER, Short LL, Glasebrook AL, Bryant HU.	J. Med. Chem.	1997	40	146		Binding	In vitro relative binding affinity by competition with [3H]17-beta-estradiol for estrogen receptor in MCF-7 cell lysate		logRBA	1.531		alpha		
84449-90-1	599	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU.	J. Med. Chem.	1998	41	1272		Binding	Relative binding affinity of Estrogen receptor measured by using [3H]17-beta-estradiol		logRBA	1.531		alpha		
84449-90-1	600	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4		Bioorg. Med. Chem. Lett.	1996	6	201		Binding	Binding affinity against estrogen receptor relative to [3H]estradiol		logRBA	1.531		alpha		
84449-90-1	601	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4		Bioorg. Med. Chem. Lett.	1997	7	887		Binding	Affinity against estrogen receptor in MCF-7 cell lysate by competitive displacement of [3H]estradiol		logRBA	1.531		alpha		
84449-90-1	602	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Smith RA, Chen J, Mader MM, Muegge I, Moehler U, Katti S, Marrero D, Stirtan WG, Weaver DR, Xiao H, Carley W.	Bioorg. Med. Chem. Lett.	2002	12	2875		Binding	Binding affinity for Estrogen receptor alpha (ER alpha) receptor		logRBA	1.456		alpha		
84449-90-1	603	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Christiansen LB, Wenckens M, Bury PS, Gissel B, Hansen BS, Thorpe SM, Jacobsen P, Kanstrup A, Jurgensen AS, Naerum L, Wassermann K.	Bioorg. Med. Chem. Lett.	2002	12	17		Binding	Displacement of [3H]17-beta-estradiol from Estrogen receptor of rabbit uterine tissue	Rabbit	logRBA	0.812		alpha		
84449-90-1	604	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Binding	Percent maximal inhibition of transcriptional activation stimulated by 1 nM 17 beta-estradiol in T47D cells expressing estrogen receptor alpha	Human	INH	113	%	alpha		
84449-90-1	605	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR.	J. Med. Chem.	2007	50	2682		Binding	Displacement of [3H]estradiol from human recombinant ERalpha	Human	IC50	20.6	nM	alpha		
84449-90-1	606	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS.	J. Med. Chem.	2001	44	1654		Binding	In vitro inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha	Human	IC50	4	nM	alpha		
84449-90-1	607	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Morgan JD 2nd, Mosley RT, Birzin ET, Frisch K, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2003	13	479		Binding	Binding affinity for Human Estrogen receptor-alpha	Human	IC50	1.8	nM	alpha		
84449-90-1	608	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Chen HY, Kim S, Wu JY, Birzin ET, Chan W, Yang YT, Dahllund J, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	2551		Binding	Binding affinity towards human estrogen receptor alpha	Human	IC50	1.8	nM	alpha		
84449-90-1	609	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Morgan JD 2nd, Chan W, Birzin ET, Pai LY, Hayes EC, DaSilva CA, Mosley RT, Yang YT, Rohrer SP, Dininno F, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	5124		Binding	Inhibition of binding to recombinant human ERalpha by scintillation proximity assay	Human	IC50	1.8	nM	alpha		
84449-90-1	610	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Binding	Binding affinity to ERalpha	Human	IC50	1.8	nM	alpha		
84449-90-1	611	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Ji Q, Gao J, Wang J, Yang C, Hui X, Yan X, Wu X, Xie Y, Wang MW.	Bioorg. Med. Chem. Lett.	2005	15	2891		Binding	Inhibitino of [3H]17-beta-estradiol binding to human estrogen receptor alpha	Human	IC50	0.89	nM	alpha		
84449-90-1	612	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Yang C, Xu G, Li J, Wu X, Liu B, Yan X, Wang M, Xie Y.	Bioorg. Med. Chem. Lett.	2005	15	1505		Binding	Inhibition of estrogen receptor alpha	Human	IC50	0.73	nM	alpha		
84449-90-1	613	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Binding	In vitro inhibition of transcriptional activation induced by 1 nM 17-beta estradiol in T47D cells expressing estrogen receptor alpha	Human	IC50	0.7	nM	alpha		
84449-90-1	614	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Wallace OB, Lauwers KS, Jones SA, Dodge JA.	Bioorg. Med. Chem. Lett.	2003	13	1907		Binding	Binding affinity for estrogen receptor alpha	Human	Ki	0.4	nM	alpha		
84449-90-1	615	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Binding	Inhibition of [3H]estradiol binding to human estrogen receptor alpha expressed in HeLa cells	Human	logRBA	2.105		alpha		
84449-90-1	616	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha.	Human	logRBA	2.038		alpha		
84449-90-1	617	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor alpha in competitive binding assay	Human	logRBA	1.859		alpha		
84449-90-1	618	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Morgan JD 2nd, Chen HY, Wu JY, Gude C, Kim S, Chan W, Birzin ET, Tien Yang Y, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3861		Binding	Binding potency for human ER alpha	Human	logRBA	1.859		alpha		
84449-90-1	619	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Morgan JD 2nd, Wu JY, Chen HY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3865		Binding	Binding potency for human ER alpha	Human	logRBA	1.859		alpha		
84449-90-1	620	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Dininno F, Morgan JD 2nd, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PM, Sharma N, Li Y, Zhang Z, Hayes EC, Dasilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	107		Binding	Inhibition of bindign to recombinant human estrogen receptor alpha	Human	logRBA	1.859		alpha		
84449-90-1	621	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY, Yang YT, Mosley RT, Fitzgerald PM, Sharma N, Dahllund J, Thorsell AG, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	J. Med. Chem.	2004	47	2171		Binding	Binding affinity towards human recombinant Estrogen receptor alpha was determined	Human	logRBA	1.859		alpha		
84449-90-1	622	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Binding	Binding affinity to ERalpha	Human	logRBA	1.806		alpha		
84449-90-1	623	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Schmid CR, Sluka JP, Duke KM, Glasebrook AW.	Bioorg. Med. Chem. Lett.	1999	9	523		Binding	Displacement of [3H]17-beta-estradiol from estrogen receptor of MCF-7 cell lysates relative to 17-beta-estradiol	Human	logRBA	1.531		alpha		
84449-90-1	624	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Schmid CR, Glasebrook AL, Misner JW, Stephenson GA.	Bioorg. Med. Chem. Lett.	1999	9	1137		Binding	Displacement of [3H]17-beta-estradiol from estrogen receptor of MCF-7 cell lysate as relative binding affinity	Human	logRBA	1.531		alpha		
84449-90-1	625	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Sibley R, Hatoum-Mokdad H, Schoenleber R, Musza L, Stirtan W, Marrero D, Carley W, Xiao H, Dumas J.	Bioorg. Med. Chem. Lett.	2003	13	1919		Binding	In vitro binding affinity for estrogen receptor alpha	Human	logRBA	1.456		alpha		
84449-90-1	626	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jones CD, Blaszczak LC, Goettel ME, Suarez T, Crowell TA, Mabry TE, Ruenitz PC, Srivatsan V.	J. Med. Chem.	1992	35	931		Binding	Binding affinity for Estrogen receptor in MCF-Cells relative to estradiol	Human	logRBA	0.255		alpha		
84449-90-1	627	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jones CD, Blaszczak LC, Goettel ME, Suarez T, Crowell TA, Mabry TE, Ruenitz PC, Srivatsan V.	J. Med. Chem.	1992	35	931		Binding	Displacement of [3H]estradiol from Estrogen receptor in MCF-7 cells	Human	logRBA	0.247		alpha		
84449-90-1	628	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR.	J. Med. Chem.	2007	50	2682		Binding	Displacement of [3H]estradiol from human recombinant ERalpha relative to estradiol	Human	logRBA	-0.041		alpha		
84449-90-1	629	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Morgan JD 2nd, Mosley RT, Birzin ET, Frisch K, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2003	13	479		Binding	Binding affinity for Rat Estrogen receptor-alpha	Rat	IC50	0.7	nM	alpha		
84449-90-1	630	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Kim S, Wu J, Chen HY, Birzin ET, Chan W, Yang YT, Colwell L, Li S, Dahllund J, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	2741		Binding	Displacement of [3H]17-beta-estradiol from full length human estrogen receptor alpha	Human	IC50	1.8	nM	alpha	Full-length	
84449-90-1	631	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Chen HY, Kim S, Wu JY, Chan W, Birzin ET, Yang YT, Pai LY, Hayes EC, DaSilva CA, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	3912		Binding	human estrogen receptor alpha binding using scintillation proximity assay	Human	logRBA	2.269		alpha	Full-length	
84449-90-1	632	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Fang J, Akwabi-Ameyaw A, Britton JE, Katamreddy SR, Navas F 3rd, Miller AB, Williams SP, Gray DW, Orband-Miller LA, Shearin J, Heyer D.	Bioorg. Med. Chem. Lett.	2008	18	5075		Binding	Displacement of [3H]estradiol from full length biotinylated human ERalpha by scintillation proximity assay	Human	logRBA	2		alpha	Full-length	
84449-90-1	633	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	1.839		alpha	Full-length	
84449-90-1	634	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	1.77		alpha	Full-length	
84449-90-1	635	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	1.399		alpha	Full-length	
84449-90-1	636	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	1.294		alpha	Full-length	
84449-90-1	637	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	1.732		alpha	Full-length	
84449-90-1	638	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z.	J. Med. Chem.	2009	52	7544		Binding	Inhibition of fluormone ES2 binding to estrogen receptor beta after 1 hr by fluorescence polarization assay		IC50	8.2	nM	beta		
84449-90-1	639	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Drewry DH, Jones SA, Stewart EL, Weaver SL, Wiethe RW.	Bioorg. Med. Chem. Lett.	2001	11	1939		Binding	Ability to displace [3H]17-beta-estradiol from Estrogen receptor beta by scintillation proximity assay.		logRBA	1.544		beta		
84449-90-1	640	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Smith RA, Chen J, Mader MM, Muegge I, Moehler U, Katti S, Marrero D, Stirtan WG, Weaver DR, Xiao H, Carley W.	Bioorg. Med. Chem. Lett.	2002	12	2875		Binding	Binding affinity for Estrogen receptor beta(ER beta) receptor		logRBA	-0.371		beta		
84449-90-1	641	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR.	J. Med. Chem.	2007	50	2682		Binding	Displacement of [3H]estradiol from human recombinant ERbeta	Human	IC50	557	nM	beta		
84449-90-1	642	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Binding	Percent maximal inhibition of 1 nM 17-beta-estradiol induced transcriptional activation in T47D cells expressing estrogen receptor beta	Human	INH	120	%	beta		
84449-90-1	643	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS.	J. Med. Chem.	2001	44	1654		Binding	In vitro inhibitory concentration against [3H]17-beta-estradiol binding to human estrogen receptor 2	Human	IC50	43	nM	beta		
84449-90-1	644	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Yang C, Xu G, Li J, Wu X, Liu B, Yan X, Wang M, Xie Y.	Bioorg. Med. Chem. Lett.	2005	15	1505		Binding	Inhibition of estrogen receptor beta	Human	IC50	18.9	nM	beta		
84449-90-1	645	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Binding	In vitro inhibition of 1 nM 17-beta-estradiol induced transcriptional activation in T47D cells expressing estrogen receptor beta	Human	IC50	15	nM	beta		
84449-90-1	646	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Morgan JD 2nd, Mosley RT, Birzin ET, Frisch K, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2003	13	479		Binding	Binding affinity for Human Estrogen receptor-beta	Human	IC50	12	nM	beta		
84449-90-1	647	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Chen HY, Kim S, Wu JY, Birzin ET, Chan W, Yang YT, Dahllund J, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	2551		Binding	Binding affinity towards human estrogen receptor beta (ERbeta)	Human	IC50	12	nM	beta		
84449-90-1	648	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Morgan JD 2nd, Chan W, Birzin ET, Pai LY, Hayes EC, DaSilva CA, Mosley RT, Yang YT, Rohrer SP, Dininno F, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	5124		Binding	Inhibition of binding to recombinant human ERbeta by scintillation proximity assay	Human	IC50	12	nM	beta		
84449-90-1	649	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Binding	Binding affinity to ERbeta	Human	IC50	8.2	nM	beta		
84449-90-1	650	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Wallace OB, Lauwers KS, Jones SA, Dodge JA.	Bioorg. Med. Chem. Lett.	2003	13	1907		Binding	Binding affinity for estrogen receptor beta	Human	Ki	4.3	nM	beta		
84449-90-1	651	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Ji Q, Gao J, Wang J, Yang C, Hui X, Yan X, Wu X, Xie Y, Wang MW.	Bioorg. Med. Chem. Lett.	2005	15	2891		Binding	Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor beta	Human	IC50	1.6	nM	beta		
84449-90-1	652	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Binding	Binding affinity to ERbeta	Human	logRBA	1.763		beta		
84449-90-1	653	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta.	Human	logRBA	0.965		beta		
84449-90-1	654	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Binding	Inhibition of [3H]estradiol binding to human estrogen receptor beta expressed in HeLa cells	Human	logRBA	0.965		beta		
84449-90-1	655	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay	Human	logRBA	0.962		beta		
84449-90-1	656	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Morgan JD 2nd, Chen HY, Wu JY, Gude C, Kim S, Chan W, Birzin ET, Tien Yang Y, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3861		Binding	Binding potency for human ER beta	Human	logRBA	0.962		beta		
84449-90-1	657	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Morgan JD 2nd, Wu JY, Chen HY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3865		Binding	Binding potency for human ER beta	Human	logRBA	0.962		beta		
84449-90-1	658	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Dininno F, Morgan JD 2nd, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PM, Sharma N, Li Y, Zhang Z, Hayes EC, Dasilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	107		Binding	Inhibition of binding to recombinant human estrogen receptor beta	Human	logRBA	0.962		beta		
84449-90-1	659	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Kim S, Wu JY, Birzin ET, Frisch K, Chan W, Pai LY, Yang YT, Mosley RT, Fitzgerald PM, Sharma N, Dahllund J, Thorsell AG, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	J. Med. Chem.	2004	47	2171		Binding	Binding affinity towards human recombinant Estrogen receptor beta was determined	Human	logRBA	0.962		beta		
84449-90-1	660	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Sibley R, Hatoum-Mokdad H, Schoenleber R, Musza L, Stirtan W, Marrero D, Carley W, Xiao H, Dumas J.	Bioorg. Med. Chem. Lett.	2003	13	1919		Binding	In vitro binding affinity for estrogen receptor beta	Human	logRBA	-0.371		beta		
84449-90-1	661	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR.	J. Med. Chem.	2007	50	2682		Binding	Displacement of [3H]estradiol from human recombinant ERbeta relative to estradiol	Human	logRBA	-1.523		beta		
84449-90-1	662	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Morgan JD 2nd, Mosley RT, Birzin ET, Frisch K, Rohrer SP, Hammond ML.	Bioorg. Med. Chem. Lett.	2003	13	479		Binding	Binding affinity foor Rat Estrogen receptor-beta	Rat	IC50	3.4	nM	beta		
84449-90-1	663	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Rosati RL, Da Silva Jardine P, Cameron KO, Thompson DD, Ke HZ, Toler SM, Brown TA, Pan LC, Ebbinghaus CF, Reinhold AR, Elliott NC, Newhouse BN, Tjoa CM, Sweetnam PM, Cole MJ, Arriola MW, Gauthier JW, Crawford DT, Nickerson DF, Pirie CM, Qi H, Simmons HA, Tkalcevic GT.	J. Med. Chem.	1998	41	2928		Binding	Inhibition of estradiol binding to estrogen receptor	Rat	logRBA	1.282		beta		
84449-90-1	664	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Kim S, Wu J, Chen HY, Birzin ET, Chan W, Yang YT, Colwell L, Li S, Dahllund J, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	2741		Binding	Displacement of [3H]17-beta-estradiol from full length human estrogen receptor beta	Human	IC50	12	nM	beta	Full-length	
84449-90-1	665	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Chen HY, Kim S, Wu JY, Chan W, Birzin ET, Yang YT, Pai LY, Hayes EC, DaSilva CA, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	3912		Binding	human estrogen receptor beta binding using scintillation proximity assay	Human	logRBA	1.763		beta	Full-length	
84449-90-1	666	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	1.307		beta	Full-length	
84449-90-1	667	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Fang J, Akwabi-Ameyaw A, Britton JE, Katamreddy SR, Navas F 3rd, Miller AB, Williams SP, Gray DW, Orband-Miller LA, Shearin J, Heyer D.	Bioorg. Med. Chem. Lett.	2008	18	5075		Binding	Displacement of [3H]estradiol from full length biotinylated human ERbeta by scintillation proximity assay	Human	logRBA	0.939		beta	Full-length	
84449-90-1	668	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	0.728		beta	Full-length	
84449-90-1	669	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	1.204		beta	Full-length	
84449-90-1	670	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	0.422		beta	Full-length	
84449-90-1	671	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	0.038		beta	Full-length	
84449-90-1	672	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Reporter Gene	Agonist activity at estrogen receptor in Ishikawa cells at 10 uM	Human	Agonism	-10000				
84449-90-1	673	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Reporter Gene	Agonist activity at estrogen receptor in MCF7 cells at 10 uM	Human	Agonism	-10000				
84449-90-1	674	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Reporter Gene	Inhibition of estrogen receptor in MCF7 cells	Human	IC50	222	nM			
84449-90-1	675	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Reporter Gene	Inhibition of 17-beta-estradiol mediated luciferase transcription in HeLa cells expressing human estrogen receptor alpha; ERE assay	Human	IC50	2.4	nM	alpha		
84449-90-1	676	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS.	J. Med. Chem.	2001	44	1654		Reporter Gene	In vitro antagonist effect on estrogen receptor alpha transcriptional activation in MCF-7 cells against 10 pM 17-beta-estradiol	Human	IC50	0.72	nM	alpha		
84449-90-1	677	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Xu S, Li N, Ning MM, Zhou CH, Yang QR, Wang MW.	J. Nat. Prod.	2006	69	247		Reporter Gene	Antagonist activity at human ERalpha expressed in african green monkey CV1 cells assessed as inhibition of estrogen like activity after 24 hrs by luciferase reporter gene assay	Human	IC50	0.46	nM	alpha		
84449-90-1	678	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Antagonistic activity against estrogen receptor alpha in presence of 0.1 nM estradiol	Human	Ki	0.03	nM	alpha		
84449-90-1	679	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Reporter Gene	Agonist effect on transcriptional activation in T47D cells expressing estrogen receptor alpha	Human	logRA	-10000		alpha		
84449-90-1	680	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Reporter Gene	Inhibition of 17-beta-estradiol mediated luciferase transcription in HeLa cells expressing human estrogen receptor beta; ERE assay	Human	IC50	341	nM	beta		
84449-90-1	681	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Antagonistic activity against estrogen receptor beta in presence of 0.1 nM estradiol	Human	Ki	4.5	nM	beta		
84449-90-1	682	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.	J. Med. Chem.	2002	45	5492		Reporter Gene	Agonist effect on transcriptional activation of T47D cells expressing human estrogen receptor beta	Human	logRA	-10000		beta		
84449-90-1	683	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Grese TA, Cho S, Finley DR, Godfrey AG, Jones CD, Lugar CW 3rd, Martin MJ, Matsumoto K, Pennington LD, Winter MA, Adrian MD, Cole HW, Magee DE, Phillips DL, Rowley ER, Short LL, Glasebrook AL, Bryant HU.	J. Med. Chem.	1997	40	146		Cell Proliferation	Antagonism of estrogen action in a mammary tumor cell line was assayed via inhibition of MCF-7 cell proliferation stimulated by 10 e-11 M 17-beta-estradiol (in vitro)		IC50	0.2	nM			
84449-90-1	684	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Sarachine MJ, Janjic JM, Wipf P, Day BW.	Bioorg. Med. Chem. Lett.	2009	19	2404		Cell Proliferation	Growth inhibition of estrogen receptor deficient human MDA-MB-231 cells at 3.2 nM to 50 uM after 72 hrs by MTS assay	Human	GI50	-10000				
84449-90-1	685	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z.	J. Med. Chem.	2009	52	7544		Cell Proliferation	Agonist activity at estrogen receptor in human MCF7 cells assessed as 17-beta-estradiol-induced cell proliferation at 10 uM after 24 hrs by [14C]thymidine incorporation assay	Human	IC50	-10000				
84449-90-1	686	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z.	J. Med. Chem.	2009	52	7544		Cell Proliferation	Antagonist activity at estrogen receptor in human MCF7 cells assessed as 17-beta-estradiol-induced cell proliferation after 24 hrs by [14C]thymidine incorporation assay	Human	IC50	222	nM			
84449-90-1	687	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Smith RA, Chen J, Mader MM, Muegge I, Moehler U, Katti S, Marrero D, Stirtan WG, Weaver DR, Xiao H, Carley W.	Bioorg. Med. Chem. Lett.	2002	12	2875		Cell Proliferation	Antagonist activity in MCF-7 breast tumor cell proliferation assay, based on pS2 gene expression at 10 nM	Human	Antagonism	94	%			
84449-90-1	688	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Cell Proliferation	Inhibition of estrogen receptor in Ishikawa cells	Human	IC50	23	nM			
84449-90-1	689	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	McKie JA, Bhagwat SS, Brady H, Doubleday M, Gayo L, Hickman M, Jalluri RK, Khammungkhune S, Kois A, Mortensen D, Richard N, Sapienza J, Shevlin G, Stein B, Sutherland M.	Bioorg. Med. Chem. Lett.	2004	14	3407		Cell Proliferation	Antiproliferative activity against MCF-7 cell line	Human	IC50	4.9	nM			
84449-90-1	690	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Cell Proliferation	Inhibition of estrogen-mediated human breast adenocarcinoma (MCF-7) cell proliferation	Human	IC50	1.4	nM			
84449-90-1	691	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Morgan JD 2nd, Chen HY, Wu JY, Gude C, Kim S, Chan W, Birzin ET, Tien Yang Y, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3861		Cell Proliferation	In vitro antagonistic activity against MCF-7 cells was tested using proliferation assay	Human	IC50	0.8	nM			
84449-90-1	692	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, DiNinno F, Morgan JD 2nd, Wu JY, Chen HY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Zhang Z, Hayes EC, DaSilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	3865		Cell Proliferation	In vitro antagonistic activity against MCF-7 cells was tested using proliferation assay	Human	IC50	0.8	nM			
84449-90-1	693	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Blizzard TA, Dininno F, Morgan JD 2nd, Chen HY, Wu JY, Kim S, Chan W, Birzin ET, Yang YT, Pai LY, Fitzgerald PM, Sharma N, Li Y, Zhang Z, Hayes EC, Dasilva CA, Tang W, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2005	15	107		Cell Proliferation	In vitro inhibition of estradiol-stimulated MCF-7 breast cancer cell proliferation	Human	IC50	0.8	nM			
84449-90-1	694	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Schmid CR, Glasebrook AL, Misner JW, Stephenson GA.	Bioorg. Med. Chem. Lett.	1999	9	1137		Cell Proliferation	Inhibition of 17-beta-estradiol (10e-11 M) mediated MCF-7 cell proliferation	Human	IC50	0.34	nM			
84449-90-1	695	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Wallace OB, Lauwers KS, Jones SA, Dodge JA.	Bioorg. Med. Chem. Lett.	2003	13	1907		Cell Proliferation	Inhibition of estradiol-stimulated MCF-7 breast adenocarcinoma cell proliferation	Human	IC50	0.2	nM			
84449-90-1	696	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU.	J. Med. Chem.	1998	41	1272		Cell Proliferation	Inhibition of estrogen-stimulated MCF-7 cell proliferation	Human	IC50	0.2	nM			
84449-90-1	697	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4		Bioorg. Med. Chem. Lett.	1997	7	887		Cell Proliferation	Antagonist effect in breast tissue was assayed by inhibition of estrogen stimulated MCF-7 cell proliferation	Human	IC50	0.2	nM			
84449-90-1	698	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Schmid CR, Sluka JP, Duke KM, Glasebrook AW.	Bioorg. Med. Chem. Lett.	1999	9	523		Cell Proliferation	In vitro inhibition of estrogen-stimulated MCF-7 cell proliferation	Human	IC50	0.2	nM			
84449-90-1	699	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Smith RA, Chen J, Mader MM, Muegge I, Moehler U, Katti S, Marrero D, Stirtan WG, Weaver DR, Xiao H, Carley W.	Bioorg. Med. Chem. Lett.	2002	12	2875		Cell Proliferation	Agonist activity in MCF-7 breast tumor cell proliferation assay, based on pS2 gene expression at 10 uM	Human	Agonism	-33	%			
84449-90-1	700	4	2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol	C28H27NO4S	473.58	5.34		Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.	J. Med. Chem.	2005	48	364		Cell Proliferation	Percent agonist activity against human breast adenocarcinoma (MCF-7) cell proliferation	Human	logRE	1.342				
72732-26-4	701	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	2				
72732-26-4	702	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cells	Human	logRBA	0.462				
72732-26-4	703	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM.	Toxicol. Sci. 	2000	54	138		Binding	relative binding affinity (RBA) for ER competitive-binding assays	Rat	logRBA	2.244				
72732-26-4	704	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	2.24				
72732-26-4	705	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	1.8				
72732-26-4	706	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Mouse uterine cytosol	Mouse	logRBA	1.15				
72732-26-4	707	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	2.435			LBD	
72732-26-4	708	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	2.386			LBD	
72732-26-4	709	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	2.225			LBD	
72732-26-4	710	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Ito C, Itoigawa M, Kumagaya M, Okamoto Y, Ueda K, Nishihara T, Kojima N, Furukawa H.	J. Nat. Prod.	2006	69	138		Binding	Antiestrogenic activity at estrogen receptor alpha expressed in yeast cells assessed as inhibition of 17-beta-estradiol-induced beta-galactosidase activity by two hybrid assay		IC50	4400	nM	alpha		
72732-26-4	711	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Binding	Inhibitory concentration against estrogen receptor alpha using radioligand binding assay.		logRBA	2.217		alpha		
72732-26-4	712	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McKie JA, Bhagwat SS, Brady H, Doubleday M, Gayo L, Hickman M, Jalluri RK, Khammungkhune S, Kois A, Mortensen D, Richard N, Sapienza J, Shevlin G, Stein B, Sutherland M.	Bioorg. Med. Chem. Lett.	2004	14	3407		Binding	Binding affinity against estrogen receptor alpha relative to E2		logRBA	1.681		alpha		
72732-26-4	713	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Pigeon P, Top S, VessiÃ¨res A, HuchÃ© M, Hillard EA, Salomon E, Jaouen G.	J. Med. Chem.	2005	48	2814		Binding	Relative binding affinity for Estrogen receptor alpha		logRBA	1.585		alpha		
72732-26-4	714	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Grese TA, Cho S, Finley DR, Godfrey AG, Jones CD, Lugar CW 3rd, Martin MJ, Matsumoto K, Pennington LD, Winter MA, Adrian MD, Cole HW, Magee DE, Phillips DL, Rowley ER, Short LL, Glasebrook AL, Bryant HU.	J. Med. Chem.	1997	40	146		Binding	In vitro relative binding affinity by competition with [3H]17-beta-estradiol for estrogen receptor in MCF-7 cell lysate		logRBA	1.556		alpha		
72732-26-4	715	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU.	J. Med. Chem.	1998	41	1272		Binding	Relative binding affinity of Estrogen receptor measured by using [3H]17-beta-estradiol		logRBA	1.556		alpha		
72732-26-4	716	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Binding	Displacement of fluorescein labeled estradiol from human recombinant ERalpha expressed in baculovirus infected insect cells by fluorescence polarization assay	Human	IC50	40	nM	alpha		
72732-26-4	717	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kim YW, Mobley JA, Brueggemeier RW.	Bioorg. Med. Chem. Lett.	2003	13	1475		Binding	Binding affinity for Estrogen receptor alpha	Human	EC50	15.7	nM	alpha		
72732-26-4	718	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Binding	Binding affinity towards human estrogen receptor alpha in a competitive binding assay using fluorescently labelled estradiol	Human	Ki	5.7	nM	alpha		
72732-26-4	719	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Chao EY, Collins JL, Gaillard S, Miller AB, Wang L, Orband-Miller LA, Nolte RT, McDonnell DP, Willson TM, Zuercher WJ.	Bioorg. Med. Chem. Lett.	2006	16	821		Binding	Displacement of [3H]estradiol from ERalpha	Human	IC50	2	nM	alpha		
72732-26-4	720	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schmidt JM, Mercure J, Tremblay GB, PagÃ© M, Kalbakji A, Feher M, Dunn-Dufault R, Peter MG, Redden PR.	J. Med. Chem.	2003	46	1408		Binding	In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor alpha	Human	Ki	0.25	nM	alpha		
72732-26-4	721	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hoekstra WJ, Patel HS, Liang X, Blanc JB, Heyer DO, Willson TM, Iannone MA, Kadwell SH, Miller LA, Pearce KH, Simmons CA, Shearin J.	J. Med. Chem.	2005	48	2243		Binding	Binding affinity for human estrogen receptor alpha	Human	logRBA	1.9		alpha		
72732-26-4	722	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative affinity for estrogen receptor of Human Breast cancer or normal uterine cytosol (3.3%ethanol) compared to estradiol	Human	logRBA	1.641		alpha		
72732-26-4	723	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kim YW, Mobley JA, Brueggemeier RW.	Bioorg. Med. Chem. Lett.	2003	13	1475		Binding	Relative binding affinity for Estrogen receptor alpha compared to estradiol	Human	logRBA	1.415		alpha		
72732-26-4	724	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	2.38		alpha		
72732-26-4	725	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Binding	Relative binding affinity to the estrogen receptor in lamb uterus cytosol	Sheep	logRBA	2.386		alpha		
72732-26-4	726	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	2.41		alpha	Full-length	
72732-26-4	727	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	2.278		alpha	Full-length	
72732-26-4	728	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	2.25		alpha	Full-length	
72732-26-4	729	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	2.19		alpha	Full-length	
72732-26-4	730	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	1.693		alpha	Full-length	
72732-26-4	731	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	2.326		alpha	Full-length	
72732-26-4	732	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Binding	Inhibitory concentration against estrogen receptor 2 using radioligand binding assay.		logRBA	2.058		beta		
72732-26-4	733	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Pigeon P, Top S, VessiÃ¨res A, HuchÃ© M, Hillard EA, Salomon E, Jaouen G.	J. Med. Chem.	2005	48	2814		Binding	Relative binding affinity for Estrogen receptor beta		logRBA	1.267		beta		
72732-26-4	734	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Binding	Displacement of fluorescein labeled estradiol from human recombinant ERbeta expressed in baculovirus infected insect cells by fluorescence polarization assay	Human	IC50	20	nM	beta		
72732-26-4	735	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Binding	Binding affinity towards human estrogen receptor beta in a competitive binding assay using fluorescently labelled estradiol	Human	Ki	1.7	nM	beta		
72732-26-4	736	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Schmidt JM, Mercure J, Tremblay GB, PagÃ© M, Kalbakji A, Feher M, Dunn-Dufault R, Peter MG, Redden PR.	J. Med. Chem.	2003	46	1408		Binding	In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor beta	Human	Ki	0.16	nM	beta		
72732-26-4	737	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hoekstra WJ, Patel HS, Liang X, Blanc JB, Heyer DO, Willson TM, Iannone MA, Kadwell SH, Miller LA, Pearce KH, Simmons CA, Shearin J.	J. Med. Chem.	2005	48	2243		Binding	Binding affinity for human estrogen receptor beta	Human	logRBA	2		beta		
72732-26-4	738	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Ruenitz PC, Bagley JR, Mokler CM.	J. Med. Chem.	1982	25	1056		Binding	Percent inhibition of [3H]estradiol binding to cytoplasmic estrogen receptor of rat uterus	Rat	INH	37.2	%	beta		
72732-26-4	739	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Ruenitz PC, Bagley JR, Nanavati NT.	J. Med. Chem.	1988	31	1471		Binding	In vitro displacement of 3 nM [3H]4-hydroxytamoxifen from estrogen receptor of rat uterine cystol	Rat	EC50	6	nM	beta		
72732-26-4	740	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hardcastle IR, Rowlands MG, Houghton J, Parr IB, Potter GA, Jarman M, Edwards KJ, Laughton CA, Trent JO, Neidle S.	J. Med. Chem.	1995	38	241		Binding	Receptor binding affinity(RBA) for rat uterine cytosolic estrogen receptor relative to estradiol	Rat	logRBA	2		beta		
72732-26-4	741	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Binding	Relative binding affinity against estrogen receptor in calf uterus cytosol using [3H]E2 as radioligand, incubated at 5 hours at 25 degree Centigrade.	Cattle	logRBA	2.386		beta		
72732-26-4	742	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	DorÃ© JC, Gilbert J, Bignon E, Crastes de Paulet A, Ojasoo T, Pons M, Raynaud JP, Miquel JF.	J. Med. Chem.	1992	35	573		Binding	Relative binding affinity was measured on calf uterus estrogen receptor after 5 hr at 25C.	Cattle	logRBA	2.386		beta		
72732-26-4	743	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Binding	Relative binding affinity against estrogen receptor in calf uterus cytosol using [3H]E2 as radioligand, incubated at 2 hours at 0 degree Centigrade.	Cattle	logRBA	2.09		beta		
72732-26-4	744	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2003	46	1484		Binding	Displacement of [3H]E2 from calf uterine estrogen receptor	Cattle	logRBA	1.193		beta		
72732-26-4	745	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	2.079		beta	Full-length	
72732-26-4	746	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	2.53		beta	Full-length	
72732-26-4	747	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2.53		beta	Full-length	
72732-26-4	748	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2.365		beta	Full-length	
72732-26-4	749	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2003	46	1484		Reporter Gene	Inhibition of estradiol induced estrogen receptor transcriptional activation in MCF-7-2a cells	Human	IC50	7	nM			
72732-26-4	750	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Reporter Gene	Anti-estrogenicity for 50% inhibition of the MVLN cell luciferase activity due to 0.1 nM E2 (estradiol)	Human	IC50	3	nM			
72732-26-4	751	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	1.748				
72732-26-4	752	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	-2.155				
72732-26-4	753	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Lubczyk V, Bachmann H, Gust R.	J. Med. Chem.	2003	46	1484		Reporter Gene	Agonistic effect on estrogen receptor mediated transcriptional activation in MCF-7-2a cells at 1 uM compared to 10e-8 M estradiol	Human	logRA	-10000				
72732-26-4	754	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Reporter Gene	Inhibitory concentration against estrogen receptor alpha using estrogen response element (ERE) assay.		IC50	10.3	nM	alpha		
72732-26-4	755	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Antagonistic activity against estrogen receptor alpha in presence of 0.1 nM estradiol	Human	Ki	0.04	nM	alpha		
72732-26-4	756	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	-3.523		alpha	LBD	
72732-26-4	757	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Reporter Gene	Inhibitory concentration against estrogen receptor 2 using estrogen response element (ERE) assay.		IC50	32	nM	beta		
72732-26-4	758	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Clegg NJ, Paruthiyil S, Leitman DC, Scanlan TS.	J. Med. Chem.	2005	48	5989		Reporter Gene	Antagonistic activity against estrogen receptor beta in presence of 0.1 nM estradiol	Human	Ki	0.014	nM	beta		
72732-26-4	759	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Grese TA, Cho S, Finley DR, Godfrey AG, Jones CD, Lugar CW 3rd, Martin MJ, Matsumoto K, Pennington LD, Winter MA, Adrian MD, Cole HW, Magee DE, Phillips DL, Rowley ER, Short LL, Glasebrook AL, Bryant HU.	J. Med. Chem.	1997	40	146		Cell Proliferation	Antagonism of estrogen action in a mammary tumor cell line was assayed via inhibition of MCF-7 cell proliferation stimulated by 10 e-11 M 17-beta-estradiol (in vitro)		IC50	0.5	nM			
72732-26-4	760	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Cell Proliferation	Antiproliferative activity against hormone independent human MDA-MB-231 cells upto 100 nM after 72 hrs by MTT assay	Human	IC50	-10000				
72732-26-4	761	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Hardcastle IR, Rowlands MG, Houghton J, Parr IB, Potter GA, Jarman M, Edwards KJ, Laughton CA, Trent JO, Neidle S.	J. Med. Chem.	1995	38	241		Cell Proliferation	In vitro cytotoxicity against hormone-responsive MCF-7 cell line.	Human	IC50	15500	nM			
72732-26-4	762	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Cell Proliferation	Cytotoxicity against MCF-7 cells in presence of 1 uM E2 (estradiol)	Human	IC50	9400	nM			
72732-26-4	763	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Cell Proliferation	Cytostaticity against MCF-7 cells in the presence of 1 uMolar E2 (estradiol)	Human	IC50	8000	nM			
72732-26-4	764	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Gilbert J, Fuentes M, Ojasoo T, DorÃ© JC, Pons M.	J. Med. Chem.	1997	40	1104		Cell Proliferation	Cytotoxicity against MCF-7 cells in the absence of 1 uM E2 (estradiol)	Human	IC50	6000	nM			
72732-26-4	765	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG.	Bioorg. Med. Chem.	2008	16	9554		Cell Proliferation	Antiproliferative activity against estrogen receptor dependent human MCF7 cells after 72 hrs by MTT assay	Human	IC50	107	nM			
72732-26-4	766	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Cell Proliferation	Percent of inhibitory activity versus 0.1 nm [3H]estradiol against proliferation of MCF-7 cells.	Human	INH	100	%			
72732-26-4	767	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	McKie JA, Bhagwat SS, Brady H, Doubleday M, Gayo L, Hickman M, Jalluri RK, Khammungkhune S, Kois A, Mortensen D, Richard N, Sapienza J, Shevlin G, Stein B, Sutherland M.	Bioorg. Med. Chem. Lett.	2004	14	3407		Cell Proliferation	Antiproliferative activity against MCF-7 cell line	Human	IC50	24	nM			
72732-26-4	768	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Cell Proliferation	Inhibitory concentration against MCF-7 breast tumor cells using MCF-7 assay.	Human	IC50	8.5	nM			
72732-26-4	769	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU.	J. Med. Chem.	1998	41	1272		Cell Proliferation	Inhibition of estrogen-stimulated MCF-7 cell proliferation	Human	IC50	0.5	nM			
72732-26-4	770	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Halleux C, Kallen J, Keller H, Schlaeppi JM, Stark W.	J. Med. Chem.	2003	46	2945		Cell Proliferation	Percent agonistic activity in MCF-7 breast tumor cells using MCF-7 assay	Human	logRE	1.491				
72732-26-4	771	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Bignon E, Pons M, Crastes de Paulet AC, DorÃ© JC, Gilbert J, Abecassis J, Miquel JF, Ojasoo T, Raynaud JP.	J. Med. Chem.	1989	32	2092		Cell Proliferation	Percent of effective dose for [3H]estradiol against proliferation of MCF-7 cells.	Human	logRE	1				
72732-26-4	772	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	DorÃ© JC, Gilbert J, Bignon E, Crastes de Paulet A, Ojasoo T, Pons M, Raynaud JP, Miquel JF.	J. Med. Chem.	1992	35	573		Cell Proliferation	Agonistic activity in MCF-7 cell proliferation.	Human	logRE	1				
72732-26-4	773	5	4-hydroxytamoxifen	C26H29NO2	387.51	4.67		CC\\C(=C(/c1ccc(O)cc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	0.58				
56-53-1	774	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	2				
56-53-1	775	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cells	Human	logRBA	1.924				
56-53-1	776	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM.	Toxicol. Sci. 	2000	54	138		Binding	relative binding affinity (RBA) for ER competitive-binding assays	Rat	logRBA	2.602				
56-53-1	777	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	2.412				
56-53-1	778	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr.	Chem. Res. Toxicol. 	1996	9	1240		Binding	Competitive estrogen receptor binding assays using mouse uterine cytosol	Mouse	logRBA	2.57				
56-53-1	779	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Waller CL, Minor DL, McKinney JD.	Environ. Health Perspect. 	1995	103	702		Binding	Competitive binding concentration of unlabeled inhibitor yielding half-maximal specific binding relative to estradiol	Mouse	logRBA	2.398				
56-53-1	780	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Mouse uterine cytosol	Mouse	logRBA	2.181				
56-53-1	781	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Walter G, Liebl R, von Angerer E.	Bioorg. Med. Chem. Lett.	2004	14	4659		Binding	Relative binding affinity for Estrogen receptor of Calf uterine cytosol	Cattle	logRBA	1.857				
56-53-1	782	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	2.217			LBD	
56-53-1	783	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	2.114			LBD	
56-53-1	784	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	2.029			LBD	
56-53-1	785	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Adamczyk M, Reddy RE, Yu Z.	Bioorg. Med. Chem. Lett.	2002	12	1283		Binding	Displacement of radioligand from Estrogen receptor alpha		logRBA	3.013		alpha		
56-53-1	786	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS.	J. Med. Chem.	2001	44	1654		Binding	In vitro inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha	Human	IC50	3	nM	alpha		
56-53-1	787	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schmidt JM, Mercure J, Tremblay GB, PagÃ© M, Kalbakji A, Feher M, Dunn-Dufault R, Peter MG, Redden PR.	J. Med. Chem.	2003	46	1408		Binding	In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor alpha	Human	Ki	0.49	nM	alpha		
56-53-1	788	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	De Angelis M, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	2004	14	5835		Binding	Inhibition of [3H]estradiol binding to human estrogen receptor alpha	Human	logRBA	2.633		alpha		
56-53-1	789	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha.	Human	logRBA	2.301		alpha		
56-53-1	790	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative affinity for estrogen receptor of Human Breast cancer or normal uterine cytosol (3.3%ethanol) compared to estradiol	Human	logRBA	2.041		alpha		
56-53-1	791	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, MÃ©rand Y, BÃ©langer A, Labrie C, Labrie F.	J. Med. Chem.	1997	40	2117		Binding	Relative Binding Affinity for estrogen receptor in Human Breast cancer or normal uterine cytosol in 3.3%ethanol compared to estradiol	Human	logRBA	1.971		alpha		
56-53-1	792	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schmidt JM, Tremblay GB, PagÃ© M, Mercure J, Feher M, Dunn-Dufault R, Peter MG, Redden PR.	J. Med. Chem.	2003	46	1289		Binding	In vitro displacement of 0.5 nM [3H]E2 from human Estrogen receptor alpha at 10 uM	Human	logRBA	1.398		alpha		
56-53-1	793	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	1.95		alpha		
56-53-1	794	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Goswami R, Harsy SG, Heiman DF, Katzenellenbogen JA.	J. Med. Chem.	1980	23	1002		Binding	Relative binding affinity for sheep uterine estrogen receptor relative to estradiol as Ka(compound)/Ka(estradiol) x 100	Sheep	logRBA	2.477		alpha		
56-53-1	795	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	2.67		alpha	Full-length	
56-53-1	796	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Hu JY, Aizawa T.	Water Res.	2003	37	1213		Binding	human receptor binding competition assay of ER	Human	logRBA	2.584		alpha	Full-length	
56-53-1	797	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Waibel M, De Angelis M, Stossi F, Kieser KJ, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	Eur. J. Med. Chem.	2009	44	3412		Binding	Displacement of [3H]estradiol from human full length ERalpha assessed as relative binding affinity by competitive radiometric binding assay relative to estradiol	Human	logRBA	2.571		alpha	Full-length	
56-53-1	798	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	2.373		alpha	Full-length	
56-53-1	799	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	2.288		alpha	Full-length	
56-53-1	800	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	2.151		alpha	Full-length	
56-53-1	801	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	2.037		alpha	Full-length	
56-53-1	802	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	1.959		alpha	Full-length	
56-53-1	803	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	2.511		alpha	Full-length	
56-53-1	804	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	2.936		alpha	Full-length	
56-53-1	805	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	1.924		alpha	Full-length	
56-53-1	806	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS.	J. Med. Chem.	2001	44	1654		Binding	In vitro inhibitory concentration against [3H]17-beta-estradiol binding to human estrogen receptor 2	Human	IC50	4	nM	beta		
56-53-1	807	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schmidt JM, Mercure J, Tremblay GB, PagÃ© M, Kalbakji A, Feher M, Dunn-Dufault R, Peter MG, Redden PR.	J. Med. Chem.	2003	46	1408		Binding	In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor beta	Human	Ki	0.63	nM	beta		
56-53-1	808	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	De Angelis M, Katzenellenbogen JA.	Bioorg. Med. Chem. Lett.	2004	14	5835		Binding	Inhibition of [3H]estradiol binding to human estrogen receptor beta	Human	logRBA	2.447		beta		
56-53-1	809	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta.	Human	logRBA	2.426		beta		
56-53-1	810	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schmidt JM, Tremblay GB, PagÃ© M, Mercure J, Feher M, Dunn-Dufault R, Peter MG, Redden PR.	J. Med. Chem.	2003	46	1289		Binding	In vitro displacement of 0.5 nM [3H]E2 from human Estrogen receptor beta at 10 uM	Human	logRBA	1.398		beta		
56-53-1	811	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Shani J, Gazit A, Livshitz T, Biran S.	J. Med. Chem.	1985	28	1504		Binding	Displacement of [3H]E2 specific binding to estrogen receptor	Rat	IC50	4	nM	beta		
56-53-1	812	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Sadler BR, Cho SJ, Ishaq KS, Chae K, Korach KS.	J. Med. Chem.	1998	41	2261		Binding	Relative binding affinity ( relative to estradiol) to mouse estrogen receptor.	Mouse	logRBA	2.456		beta		
56-53-1	813	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2		Bioorg. Med. Chem. Lett.	1995	5	133		Binding	Binding affinity for mouse uterine cytosol estrogen receptor	Mouse	logRBA	2.456		beta		
56-53-1	814	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Hartmann RW, Heindl A, Schneider MR, Schnenberger H.	J. Med. Chem.	1986	29	322		Binding	Relative Binding Affinity (RBA) for calf uterine estrogen receptor	Cattle	logRBA	1.699		beta		
56-53-1	815	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERb binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	2.924		beta	Full-length	
56-53-1	816	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Waibel M, De Angelis M, Stossi F, Kieser KJ, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.	Eur. J. Med. Chem.	2009	44	3412		Binding	Displacement of [3H]estradiol from human full length ERbeta relative binding affinity by competitive radiometric binding assay relative to estradiol	Human	logRBA	2.444		beta	Full-length	
56-53-1	817	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	2.342		beta	Full-length	
56-53-1	818	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	2.172		beta	Full-length	
56-53-1	819	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	2.47		beta	Full-length	
56-53-1	820	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2.47		beta	Full-length	
56-53-1	821	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2.344		beta	Full-length	
56-53-1	822	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	2.223		beta	Full-length	
56-53-1	823	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	2.044		beta	Full-length	
56-53-1	824	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERa	Human	logRA	2.068				
56-53-1	825	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	2				
56-53-1	826	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	1.871				
56-53-1	827	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Gaido KW, Leonard LS, Lovell S, Gould JC, BabaÃ¯ D, Portier CJ, McDonnell DP.	Toxicol. Appl. Pharmacol.	1997	143	205		Reporter Gene	Relative Potency Ratios (RPR) for Yeast based ER Gene Transcription Assay	Human	logRA	1.804				
56-53-1	828	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERb	Rat	logRA	1.839				
56-53-1	829	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS.	J. Med. Chem.	2001	44	1654		Reporter Gene	In vitro agonist effect on estrogen receptor alpha transcriptional activation in MCF-7 cells at 10 pM	Human	EC50	0.007	nM	alpha		
56-53-1	830	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.	Human	logRA	1.523		alpha		
56-53-1	831	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	2.176		alpha	LBD	
56-53-1	832	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.	Human	logRA	2.544		beta		
56-53-1	833	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO.	Environ. Health Perspect. 	1995	103	113		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	3				
56-53-1	834	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	1.2				
56-53-1	835	6	diethylstilbestrol	C18H20O2	268.35	5.19		CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	2.59				Sc
53-16-7	836	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cells	Human	logRBA	1.279				
53-16-7	837	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	0.544				
53-16-7	838	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	1.498				
53-16-7	839	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM.	Toxicol. Sci. 	2000	54	138		Binding	relative binding affinity (RBA) for ER competitive-binding assays	Rat	logRBA	0.864				
53-16-7	840	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Mouse uterine cytosol	Mouse	logRBA	2				
53-16-7	841	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr.	Chem. Res. Toxicol. 	1996	9	1240		Binding	Competitive estrogen receptor binding assays using mouse uterine cytosol	Mouse	logRBA	1.772				
53-16-7	842	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	1.778			LBD	
53-16-7	843	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	1.699			LBD	
53-16-7	844	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	1.146			LBD	
53-16-7	845	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Wiese TE, Polin LA, Palomino E, Brooks SC.	J. Med. Chem.	1997	40	3659		Binding	Estrogen receptor (ER) binding affinity		logRBA	1.346		alpha		
53-16-7	846	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Binding	Binding affinity towards estrogen receptor alpha by [3H]17-beta-estradiol displacement.		logRBA	0.719		alpha		
53-16-7	847	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Lilienkampf A, Karkola S, Alho-Richmond S, Koskimies P, Johansson N, Huhtinen K, Vihko K, WÃ¤hÃ¤lÃ¤ K.	J. Med. Chem.	2009	52	6660		Binding	Activity at human recombinant ERalpha by fluorescence polarization assay	Human	EC50	7	nM	alpha		
53-16-7	848	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	GÃ¼ngr T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.	J. Med. Chem.	2006	49	2440		Binding	Displacement of [3H]estrone from ER alpha	Human	logRBA	1.538		alpha		
53-16-7	849	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Nussbaumer P, Winiski AP, Billich A.	J. Med. Chem.	2003	46	5091		Binding	Affinity of compound towards human estrogen receptor alpha	Human	logRBA	1.156		alpha		
53-16-7	850	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Mller G, Deluca D, Gege C, Rosinus A, Kowalik D, Peters O, Droescher P, Elger W, Adamski J, Hillisch A.	Bioorg. Med. Chem. Lett.	2009	19	6740		Binding	Displacement of [3H]17beta-estradiol from human ERalpha expressed in SF9 cells	Human	logRBA	1.115		alpha		
53-16-7	851	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor alpha.	Human	logRBA	0.699		alpha		
53-16-7	852	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Wright JS, Shadnia H, Anderson JM, Durst T, Asim M, El-Salfiti M, Choueiri C, Pratt MA, Ruddy SC, Lau R, Carlson KE, Katzenellenbogen JA, OBrien PJ, Wan L.	J. Med. Chem.	2011	54	433		Binding	Displacement of [3H]estradiol from human ERalpha after 18 to 24 hrs relative to estradiol	Human	logRBA	0.653		alpha		
53-16-7	853	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	1.65		alpha		
53-16-7	854	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	1.778		alpha	Full-length	
53-16-7	855	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	1.778		alpha	Full-length	
53-16-7	856	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	1.653		alpha	Full-length	
53-16-7	857	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Hu JY, Aizawa T.	Water Res.	2003	37	1213		Binding	human receptor binding competition assay of ER	Human	logRBA	0.842		alpha	Full-length	
53-16-7	858	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	0.322		alpha	Full-length	
53-16-7	859	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	1.447		alpha	Full-length	
53-16-7	860	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Labaree DC, Zhang JX, Harris HA, OConnor C, Reynolds TY, Hochberg RB.	J. Med. Chem.	2003	46	1886		Binding	Binding affinity against Estrogen receptor with relative to E2		logRBA	0.954		beta		
53-16-7	861	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Binding	Binding affinity towards estrogen receptor beta by [3H]17-beta-estradiol displacement.		logRBA	0.546		beta		
53-16-7	862	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Lilienkampf A, Karkola S, Alho-Richmond S, Koskimies P, Johansson N, Huhtinen K, Vihko K, WÃ¤hÃ¤lÃ¤ K.	J. Med. Chem.	2009	52	6660		Binding	Activity at human recombinant ERbeta by fluorescence polarization assay	Human	EC50	8	nM	beta		
53-16-7	863	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	GÃ¼ngr T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.	J. Med. Chem.	2006	49	2440		Binding	Displacement of [3H]estrone from ER beta	Human	logRBA	1.55		beta		
53-16-7	864	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Nussbaumer P, Winiski AP, Billich A.	J. Med. Chem.	2003	46	5091		Binding	Affinity of compound towards human estrogen receptor beta	Human	logRBA	1.196		beta		
53-16-7	865	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Wright JS, Shadnia H, Anderson JM, Durst T, Asim M, El-Salfiti M, Choueiri C, Pratt MA, Ruddy SC, Lau R, Carlson KE, Katzenellenbogen JA, OBrien PJ, Wan L.	J. Med. Chem.	2011	54	433		Binding	Displacement of [3H]estradiol from human ERbeta after 18 to 24 hrs relative to estradiol	Human	logRBA	0.58		beta		
53-16-7	866	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Binding	Inhibition of [3H]17-beta-estradiol binding to human recombinant Estrogen receptor beta.	Human	logRBA	0.325		beta		
53-16-7	867	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Labaree DC, Reynolds TY, Hochberg RB.	J. Med. Chem.	2001	44	1802		Binding	Relative binding affinity against rat uterine estrogen receptor	Rat	logRBA	1.477		beta		
53-16-7	868	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Sadek SA, Kessler WV, Shaw SM, Anderson JN, Wolf GC.	J. Med. Chem.	1982	25	1488		Binding	Relative binding affinity against Estrogen receptor as inhibition of [3H]estradiol binding in rat uterus	Rat	logRBA	1.292		beta		
53-16-7	869	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Ouellet R, Rousseau J, Brasseur N, van Lier JE, Diksic M, Westera G.	J. Med. Chem.	1984	27	509		Binding	Relative binding affinity for estrogen receptor by displacement of [3H]estradiol	Cattle	logRBA	1.362		beta		
53-16-7	870	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	DaSilva JN, van Lier JE.	J. Med. Chem.	1990	33	430		Binding	Ratio of displacement of 17-beta-[3H]-estradiol from calf uterine estrogen receptor compared to 17-beta-estradiol after 20 hr incubation in 7%DMF	Cattle	logRBA	1.176		beta		
53-16-7	871	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	DaSilva JN, van Lier JE.	J. Med. Chem.	1990	33	430		Binding	Ratio of displacement of 17-beta-[3H]-estradiol from calf uterine estrogen receptor compared to 17-beta-estradiol after 2 hr incubation	Cattle	logRBA	0.851		beta		
53-16-7	872	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERb binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	1.82		beta	Full-length	
53-16-7	873	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	1.568		beta	Full-length	
53-16-7	874	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	1.568		beta	Full-length	
53-16-7	875	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	2				
53-16-7	876	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	0.982				
53-16-7	877	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Reporter Gene	Ability to activate estrogen receptor 1-mediated transcription.		logRA	-0.398		alpha		
53-16-7	878	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.	Human	logRA	0.456		alpha		
53-16-7	879	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	2		alpha	LBD	
53-16-7	880	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Yang W, Wang Y, Ma Z, Golla R, Stouch T, Seethala R, Johnson S, Zhou R, GÃ¼ngr T, Feyen JH, Dickson JK Jr.	Bioorg. Med. Chem. Lett.	2004	14	2327		Reporter Gene	Ability to activate estrogen receptor 2-mediated transcription.		logRA	-0.253		beta		
53-16-7	881	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Schopfer U, Schoeffter P, Bischoff SF, Nozulak J, Feuerbach D, Floersheim P.	J. Med. Chem.	2002	45	1399		Reporter Gene	Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.	Human	logRA	0.523		beta		
53-16-7	882	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Wiese TE, Polin LA, Palomino E, Brooks SC.	J. Med. Chem.	1997	40	3659		Cell Proliferation	Growth response in cultures of MCF-7 (human breast cancer cell line) cells	Human	logRE	0.294				
53-16-7	883	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	0.64				
53-16-7	884	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O	Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO.	Environ. Health Perspect. 	1995	103	113		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	0				
53-16-7	885	7	estrone	C18H22O2	270.37	4.31		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	0.65				Sc
479-13-0	886	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using MCF-7 Cytosol	Human	logRBA	1.114				
479-13-0	887	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	0.203				
479-13-0	888	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr.	Chem. Res. Toxicol. 	1996	9	1240		Binding	Competitive estrogen receptor binding assays using mouse uterine cytosol	Mouse	logRBA	0.447				
479-13-0	889	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	0.491			LBD	
479-13-0	890	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	-0.155			LBD	
479-13-0	891	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	-0.62			LBD	
479-13-0	892	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor Alpha	Human	IC50	75.7	nM	alpha		
479-13-0	893	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor alpha in competitive binding assay	Human	logRBA	1.073		alpha		
479-13-0	894	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	-0.58		alpha		
479-13-0	895	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	1.973		alpha	Full-length	
479-13-0	896	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	1.601		alpha	Full-length	
479-13-0	897	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	1.301		alpha	Full-length	
479-13-0	898	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	1.079		alpha	Full-length	
479-13-0	899	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	1.027		alpha	Full-length	
479-13-0	900	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	-0.092		alpha	Full-length	
479-13-0	901	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	0.847		alpha	Full-length	
479-13-0	902	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	0.724		alpha	Full-length	
479-13-0	903	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	-0.481		alpha	Full-length	
479-13-0	904	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor beta	Human	IC50	18.6	nM	beta		
479-13-0	905	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay	Human	logRBA	1.74		beta		
479-13-0	906	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	2.073		beta	Full-length	
479-13-0	907	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	1.97		beta	Full-length	
479-13-0	908	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Rat estrogen receptor beta	Rat	logRBA	2.267		beta	Full-length	
479-13-0	909	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Kuiper GG, Carlsson B, Grandien K, Enmark E, HÃ¤ggblad J, Nilsson S, Gustafsson JA.	Endocrinology 	1997	138	863		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2.267		beta	Full-length	
479-13-0	910	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	2.197		beta	Full-length	
479-13-0	911	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	2.146		beta	Full-length	
479-13-0	912	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	2.052		beta	Full-length	
479-13-0	913	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERa	Human	logRA	2.009				
479-13-0	914	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	1.875				
479-13-0	915	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Gaido KW, Leonard LS, Lovell S, Gould JC, BabaÃ¯ D, Portier CJ, McDonnell DP.	Toxicol. Appl. Pharmacol.	1997	143	205		Reporter Gene	Relative Potency Ratios (RPR) for Yeast based ER Gene Transcription Assay	Human	logRA	0.112				
479-13-0	916	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	-0.174				
479-13-0	917	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERb	Rat	logRA	1.991				
479-13-0	918	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	-1		alpha	LBD	
479-13-0	919	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1	Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO.	Environ. Health Perspect. 	1995	103	113		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	-3				
479-13-0	920	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	-0.2				
479-13-0	921	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	-0.3				Sc
479-13-0	922	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	-0.57				oral
479-13-0	923	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	-1				
479-13-0	924	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Rat	LogRP	-1				Sc
479-13-0	925	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	-1.17				Sc
479-13-0	926	8	5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0{2,7}.0{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one	C15H8O5	268.22	1.93		Oc1ccc2c(OC(=O)c3c2oc4cc(O)ccc34)c1			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	-1.62				Sc
77538-56-8	927	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	2.349				
77538-56-8	928	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM.	Toxicol. Sci. 	2000	54	138		Binding	relative binding affinity (RBA) for ER competitive-binding assays	Rat	logRBA	2.279				
77538-56-8	929	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Waller CL, Oprea TI, Chae K, Park HK, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr.	Chem. Res. Toxicol. 	1996	9	1240		Binding	Competitive estrogen receptor binding assays using mouse uterine cytosol	Mouse	logRBA	2.938				
77538-56-8	930	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the chicken estrogen receptor	Chicken	logRBA	2.233			LBD	
77538-56-8	931	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the lizard (anole)	Lizard	logRBA	2.143			LBD	
77538-56-8	932	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	 In Vitro ER Binding Assays Glutathione-S-transferase fusion protein containing the ligand binding domain of the rainbow trout estrogen receptor	Trout	logRBA	2.033			LBD	
77538-56-8	933	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	SedlÃ¡k D, NovÃ¡k P, Kotora M, BartÅ¯nek P.	J. Med. Chem.	2010	53	4290		Binding	Ratio of 17-beta-estradiol IC50 to compound IC50 for ERalpha		logRBA	2.1		alpha		
77538-56-8	934	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]estradiol from estrogen receptor in immature rabbit	Rabbit	logRBA	2.097		alpha		
77538-56-8	935	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU.	J. Med. Chem.	1998	41	1272		Binding	Relative binding affinity of Estrogen receptor measured by using [3H]17-beta-estradiol		logRBA	2		alpha		
77538-56-8	936	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]estradiol from estrogen receptor in squirrel monkey	Monkey	logRBA	1.778		alpha		
77538-56-8	937	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Binding	Binding affinity to ERalpha	Human	IC50	2	nM	alpha		
77538-56-8	938	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	2.15		alpha		
77538-56-8	939	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	1995	38	429		Binding	Relative binding affinity was measured on estrogen receptor of lamb uterine cytosol.	Sheep	logRBA	2.431		alpha		
77538-56-8	940	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Napolitano E, Fiaschi R, Carlson KE, Katzenellenbogen JA.	J. Med. Chem.	1995	38	429		Binding	Relative binding affinity was measured on estrogen receptor of lamb uterine cytosol.	Sheep	logRBA	2.049		alpha		
77538-56-8	941	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the human ERa receptor	Human	logRBA	2.104		alpha	Full-length	
77538-56-8	942	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Glutathione-S-transferase fusion proteins consisting of the def domains of the mouse ERa receptor	Mouse	logRBA	2.072		alpha	Full-length	
77538-56-8	943	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Lal K, Sharma I, Agarwal AK, Agnihotri A, Ray S.	J. Med. Chem.	1988	31	1261		Binding	Relative binding affinity(RBA) for Estrogen receptor		logRBA	2.281		beta		
77538-56-8	944	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Gantchev TG, Ali H, van Lier JE.	J. Med. Chem.	1994	37	4164		Binding	Relative binding affinity (RBA) towards estrogen receptor.		logRBA	2		beta		
77538-56-8	945	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	SedlÃ¡k D, NovÃ¡k P, Kotora M, BartÅ¯nek P.	J. Med. Chem.	2010	53	4290		Binding	Ratio of 17-beta-estradiol IC50 to compound IC50 for ERbeta		logRBA	1.801		beta		
77538-56-8	946	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Binding	Binding affinity to ERbeta	Human	IC50	8.1	nM	beta		
77538-56-8	947	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]-estradiol from estrogen receptor in immature rat	Rat	logRBA	2		beta		
77538-56-8	948	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA.	J. Med. Chem.	1990	33	3143		Binding	Binding affinity against estrogen receptor at 25 degree C	Rat	logRBA	2.435		beta		
77538-56-8	949	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ.	J. Med. Chem.	1993	36	1619		Binding	Relative binding affinity for estrogen receptor at 25 degree C	Rat	logRBA	2.435		beta		
77538-56-8	950	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Sadek SA, Kessler WV, Shaw SM, Anderson JN, Wolf GC.	J. Med. Chem.	1982	25	1488		Binding	Relative binding affinity against Estrogen receptor as inhibition of [3H]estradiol binding in rat uterus	Rat	logRBA	2.238		beta		
77538-56-8	951	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Pomper MG, VanBrocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, Mathias CJ, Welch MJ, Katzenellenbogen JA.	J. Med. Chem.	1990	33	3143		Binding	Binding affinity against estrogen receptor at 0C	Rat	logRBA	2.086		beta		
77538-56-8	952	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ.	J. Med. Chem.	1993	36	1619		Binding	Relative binding affinity for estrogen receptor at 0C	Rat	logRBA	2.049		beta		
77538-56-8	953	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Peters RH, Crowe DF, Avery MA, Chong WK, Tanabe M.	J. Med. Chem.	1989	32	1642		Binding	Displacement of [3H]-estradiol from estrogen receptor in mature rat	Rat	logRBA	2		beta		
77538-56-8	954	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	DaSilva JN, van Lier JE.	J. Med. Chem.	1990	33	430		Binding	Ratio of displacement of 17-beta-[3H]-estradiol from calf uterine estrogen receptor compared to 17-beta-estradiol after 2 hr incubation	Cattle	logRBA	2		beta		
77538-56-8	955	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	DaSilva JN, van Lier JE.	J. Med. Chem.	1990	33	430		Binding	Ratio of displacement of 17-beta-[3H]-estradiol from calf uterine estrogen receptor compared to 17-beta-estradiol after 20 hr incubation in 7%DMF	Cattle	logRBA	2		beta		
77538-56-8	956	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERb binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	2.281		beta	Full-length	
77538-56-8	957	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Reporter Gene	Agonist activity at estrogen receptor in MCF7 cells at 10 uM	Human	Agonism	-10000				
77538-56-8	958	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Reporter Gene	Inhibition of estrogen receptor in MCF7 cells	Human	IC50	-10000				
77538-56-8	959	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Reporter Gene	Agonist activity at estrogen receptor in Ishikawa cells at 10 uM	Human	Agonism	-10000				
77538-56-8	960	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	2				
77538-56-8	961	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	1.944				
77538-56-8	962	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C		J. Health Sci.	2000	46	282		Reporter Gene	relative activity of yeast two-hybrid assay on ERa	Human	logRA10	2.176		alpha	LBD	
77538-56-8	963	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU.	J. Med. Chem.	1998	41	1272		Cell Proliferation	Inhibition of estrogen-stimulated MCF-7 cell proliferation	Human	IC50	-10000				
77538-56-8	964	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Jain N, Kanojia RM, Xu J, Jian-Zhong G, Pacia E, Lai MT, Du F, Musto A, Allan G, Hahn D, Lundeen S, Sui Z.	J. Med. Chem.	2006	49	3056		Cell Proliferation	Inhibition of estrogen receptor in Ishikawa cells	Human	IC50	-10000				
77538-56-8	965	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Fang H, Tong W, Perkins R, Soto AM, Prechtl NV, Sheehan DM.	Environ Health Perspect.	2000	108	723		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	2.05				
77538-56-8	966	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C	Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO.	Environ. Health Perspect. 	1995	103	113		Cell Proliferation	E-Screen, Relative proliferative potency (RPP) in human breast cancer estrogen-sensitive MCF-7 cells	Human	logRPP	2				
77538-56-8	967	9	ethinyl estradiol	C20H24O2	296.4	3.90		C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C			2010			http://www.fda.gov/scienceresearch/bioinformaticstools/endocrinedisruptorknowledgebase/default.htm	In Vivo	Uterotrophic Assay	Mouse	LogRP	2.97				Sc
486-66-8	968	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS, Xie Q, Dial SL, Moland CL, Sheehan DM.	Chem. Res. Toxicol.	2001	14	280		Binding	 In vitro ER binding assays using Rat uterine cytosol	Rat	logRBA	-1.638				
486-66-8	969	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, Wang G.	J. Med. Chem.	2010	53	6153		Binding	Displacement of fluorescent labeled ES2 from recombinant ERalpha relative to estradiol		logRBA	2.049		alpha		
486-66-8	970	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor Alpha	Human	IC50	-10000		alpha		
486-66-8	971	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor Alpha	Human	IC50	-10000		alpha		
486-66-8	972	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	CalderÃ³n AI, Terreaux C, Schenk K, Pattison P, Burdette JE, Pezzuto JM, Gupta MP, Hostettmann K.	J. Nat. Prod.	2002	65	1749		Binding	Displacement of [3H]estradiol from human recombinant ERalpha	Human	IC50	17000	nM	alpha		
486-66-8	973	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha	Human	IC50	6300	nM	alpha		
486-66-8	974	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor alpha	Human	Ki	1800	nM	alpha		
486-66-8	975	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor alpha in competitive binding assay	Human	logRBA	-1.221		alpha		
486-66-8	976	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O			2003			http://www.meti.go.jp/english/report/data/g020205ae.html	Binding	ER in vitro binding assay with RI-labeled estradiol as reference ligand	Rat	logRBA	-0.74		alpha		
486-66-8	977	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH.	J. Med. Chem.	2004	47	1018		Binding	Displacement of [3H]-estradiol (E2) frrom sheep uterine estrogen receptor	Sheep	Kd	5900	nM	alpha		
486-66-8	978	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Hu JY, Aizawa T.	Water Res.	2003	37	1213		Binding	human receptor binding competition assay of ER	Human	logRBA	-0.269		alpha	Full-length	
486-66-8	979	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ERa binding assays measuring displacement of a fluorescently-labeled estrogen ligand by the test substances using fluorescent polarization (FP)	Human	logRBA	-0.699		alpha	Full-length	
486-66-8	980	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERa	Human	logRBA	-1		alpha	Full-length	
486-66-8	981	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERa	Human	logRBA	-1.12		alpha	Full-length	
486-66-8	982	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERa	Human	logRBA	-1.402		alpha	Full-length	
486-66-8	983	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERa	Rat	logRBA	-1.447		alpha	Full-length	
486-66-8	984	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERa	Mouse	logRBA	-1.382		alpha	Full-length	
486-66-8	985	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Zhao L, Brinton RD.	J. Med. Chem.	2005	48	3463		Binding	Binding affinity for human Estrogen receptor beta	Human	IC50	2800	nM	beta		
486-66-8	986	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	CalderÃ³n AI, Terreaux C, Schenk K, Pattison P, Burdette JE, Pezzuto JM, Gupta MP, Hostettmann K.	J. Nat. Prod.	2002	65	1749		Binding	Displacement of [3H]estradiol from human recombinant ERbeta	Human	IC50	1200	nM	beta		
486-66-8	987	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta	Human	IC50	1100	nM	beta		
486-66-8	988	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Matsuda H, Shimoda H, Morikawa T, Yoshikawa M.	Bioorg. Med. Chem. Lett.	2001	11	1839		Binding	Inhibition of binding of 17 beta-estradiol to human Estrogen receptor beta	Human	Ki	300	nM	beta		
486-66-8	989	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Chen HY, Dykstra KD, Birzin ET, Frisch K, Chan W, Yang YT, Mosley RT, DiNinno F, Rohrer SP, Schaeffer JM, Hammond ML.	Bioorg. Med. Chem. Lett.	2004	14	1417		Binding	Binding affinity against human estrogen receptor beta (ER beta) in competitive binding assay	Human	logRBA	-0.44		beta		
486-66-8	990	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O			2002			http://iccvam.niehs.nih.gov/methods/endocrine/end_bckgnd.htm	Binding	In vitro ER binding assays using Recombinant Human ERb	Human	logRBA	-0.126		beta	Full-length	
486-66-8	991	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Human ERb	Human	logRBA	-0.242		beta	Full-length	
486-66-8	992	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Rat ERb	Rat	logRBA	-0.273		beta	Full-length	
486-66-8	993	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Binding	Relative binding affinity (RBA) of ERb	Rat	logRBA	-0.301		beta	Full-length	
486-66-8	994	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Harris HA, Bapat AR, Gonder DS, Frail DE.	Steroids	2002	67	379		Binding	Binding affinity for Mouse ERb	Mouse	logRBA	0.175		beta	Full-length	
486-66-8	995	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, Wang G.	J. Med. Chem.	2010	53	6153		Reporter Gene	Estrogenic activity at ER in human MCF7 cells assessed as increase of estradiol-induced transcriptional activity at 1 uM by luciferase reporter gene assay relative to estradiol	Human	Agonism	108.5	%			
486-66-8	996	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, Wang G.	J. Med. Chem.	2010	53	6153		Reporter Gene	Antiestrogenic activity at ER in human MCF7 cells assessed as inhibition of estradiol-induced transcriptional activity at 10 uM by luciferase reporter gene assay relative to estradiol	Human	INH	17.2	%			
486-66-8	997	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA.	Endocrinology 	1998	139	4252		Reporter Gene	Relative transactivation activity (RTA) of ERa	Human	logRA	1.987				
486-66-8	998	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Antistrogens	Human	logRA	0.732				
486-66-8	999	10	daidzein	C15H10O4	254.24	1.77		Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O	Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor C, Sauer MJ.	Environ. Health Perspect. 	1997	105	734		Reporter Gene	The recombinant yeast cell bioassay (RCBA) relative to E2 of Estrogens	Human	logRA	-3				
